{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "1ce9bc24",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "pd.set_option('display.max_columns', None)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "dce6a972",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>CIP_ENCRIPTADO</th>\n",
       "      <th>SEXO</th>\n",
       "      <th>FECHA_NACIMIENTO</th>\n",
       "      <th>SERVICIO_SALUD</th>\n",
       "      <th>TIPO_INGRESO</th>\n",
       "      <th>FECHA_INGRESO</th>\n",
       "      <th>FECHAALTA</th>\n",
       "      <th>TIPOALTA</th>\n",
       "      <th>IR_29301_PESO</th>\n",
       "      <th>IR_29301_SEVERIDAD</th>\n",
       "      <th>IR_29301_MORTALIDAD</th>\n",
       "      <th>EDAD</th>\n",
       "      <th>DIAS_ESTANCIA</th>\n",
       "      <th>HOSPITAL</th>\n",
       "      <th>DESCCRIPCION_GRD</th>\n",
       "      <th>Versión</th>\n",
       "      <th>Descripción</th>\n",
       "      <th>Categoría</th>\n",
       "      <th>Sección</th>\n",
       "      <th>Capítulo</th>\n",
       "      <th>NEXT_FECHA_INGRESO</th>\n",
       "      <th>DIAS_REINGRESO</th>\n",
       "      <th>READM_7D</th>\n",
       "      <th>READM_30D</th>\n",
       "      <th>READM_60D</th>\n",
       "      <th>READM_90D</th>\n",
       "      <th>PROCEDIMIENTO1</th>\n",
       "      <th>PROCEDIMIENTO2</th>\n",
       "      <th>PROCEDIMIENTO3</th>\n",
       "      <th>PROCEDIMIENTO4</th>\n",
       "      <th>PROCEDIMIENTO5</th>\n",
       "      <th>PROCEDIMIENTO6</th>\n",
       "      <th>PROCEDIMIENTO7</th>\n",
       "      <th>PROCEDIMIENTO8</th>\n",
       "      <th>PROCEDIMIENTO9</th>\n",
       "      <th>PROCEDIMIENTO10</th>\n",
       "      <th>PROCEDIMIENTO11</th>\n",
       "      <th>PROCEDIMIENTO12</th>\n",
       "      <th>PROCEDIMIENTO13</th>\n",
       "      <th>PROCEDIMIENTO14</th>\n",
       "      <th>PROCEDIMIENTO15</th>\n",
       "      <th>PROCEDIMIENTO16</th>\n",
       "      <th>PROCEDIMIENTO17</th>\n",
       "      <th>PROCEDIMIENTO18</th>\n",
       "      <th>PROCEDIMIENTO19</th>\n",
       "      <th>PROCEDIMIENTO20</th>\n",
       "      <th>PROCEDIMIENTO21</th>\n",
       "      <th>PROCEDIMIENTO22</th>\n",
       "      <th>PROCEDIMIENTO23</th>\n",
       "      <th>PROCEDIMIENTO24</th>\n",
       "      <th>PROCEDIMIENTO25</th>\n",
       "      <th>PROCEDIMIENTO26</th>\n",
       "      <th>PROCEDIMIENTO27</th>\n",
       "      <th>PROCEDIMIENTO28</th>\n",
       "      <th>PROCEDIMIENTO29</th>\n",
       "      <th>PROCEDIMIENTO30</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>66988070.0</td>\n",
       "      <td>HOMBRE</td>\n",
       "      <td>1977-07-12</td>\n",
       "      <td>METROPOLITANO SURORIENTE</td>\n",
       "      <td>URGENCIA</td>\n",
       "      <td>2023-03-29</td>\n",
       "      <td>2023-04-13</td>\n",
       "      <td>DOMICILIO</td>\n",
       "      <td>1.1263</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>46.0</td>\n",
       "      <td>15</td>\n",
       "      <td>Complejo Hospitalario Dr. Sótero del Río (San...</td>\n",
       "      <td>MH DISFUNCIÓN, REACCIÓN O COMPL. POR DISP., I...</td>\n",
       "      <td>CIE-v2013</td>\n",
       "      <td>Falla y rechazo de trasplante de riñón</td>\n",
       "      <td>T86 FALLA Y RECHAZO DEL TRASPLANTE DE ÓRGANOS ...</td>\n",
       "      <td>T80-T88  COMPLICACIONES DE LA ATENCIÓN QUIRÚRG...</td>\n",
       "      <td>Cap.19  LESIONES TRAUMÁTICAS, ENVENENAMIENTOS ...</td>\n",
       "      <td>2023-06-22</td>\n",
       "      <td>70.0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>5523.0</td>\n",
       "      <td>8703.0</td>\n",
       "      <td>8744.0</td>\n",
       "      <td>8952.0</td>\n",
       "      <td>8875.0</td>\n",
       "      <td>9039.0</td>\n",
       "      <td>9059.0</td>\n",
       "      <td>8929.0</td>\n",
       "      <td>9132.0</td>\n",
       "      <td>9139.0</td>\n",
       "      <td>8906.0</td>\n",
       "      <td>8913.0</td>\n",
       "      <td>9318.0</td>\n",
       "      <td>68.0</td>\n",
       "      <td>3891.0</td>\n",
       "      <td>8966.0</td>\n",
       "      <td>99.21</td>\n",
       "      <td>99.19</td>\n",
       "      <td>99.29</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>66988070.0</td>\n",
       "      <td>HOMBRE</td>\n",
       "      <td>1977-07-12</td>\n",
       "      <td>METROPOLITANO SURORIENTE</td>\n",
       "      <td>URGENCIA</td>\n",
       "      <td>2023-03-29</td>\n",
       "      <td>2023-04-13</td>\n",
       "      <td>DOMICILIO</td>\n",
       "      <td>1.1263</td>\n",
       "      <td>3.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>46.0</td>\n",
       "      <td>15</td>\n",
       "      <td>Complejo Hospitalario Dr. Sótero del Río (San...</td>\n",
       "      <td>MH DISFUNCIÓN, REACCIÓN O COMPL. POR DISP., I...</td>\n",
       "      <td>CIE-v2013</td>\n",
       "      <td>Falla y rechazo de trasplante de riñón</td>\n",
       "      <td>T86 FALLA Y RECHAZO DEL TRASPLANTE DE ÓRGANOS ...</td>\n",
       "      <td>T80-T88  COMPLICACIONES DE LA ATENCIÓN QUIRÚRG...</td>\n",
       "      <td>Cap.19  LESIONES TRAUMÁTICAS, ENVENENAMIENTOS ...</td>\n",
       "      <td>2023-06-22</td>\n",
       "      <td>70.0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>9671.0</td>\n",
       "      <td>9604.0</td>\n",
       "      <td>9396.0</td>\n",
       "      <td>9059.0</td>\n",
       "      <td>8966.0</td>\n",
       "      <td>8929.0</td>\n",
       "      <td>9132.0</td>\n",
       "      <td>8875.0</td>\n",
       "      <td>9039.0</td>\n",
       "      <td>9312.0</td>\n",
       "      <td>9318.0</td>\n",
       "      <td>9394.0</td>\n",
       "      <td>9919.0</td>\n",
       "      <td>966.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   CIP_ENCRIPTADO    SEXO FECHA_NACIMIENTO            SERVICIO_SALUD  \\\n",
       "0      66988070.0  HOMBRE       1977-07-12  METROPOLITANO SURORIENTE   \n",
       "1      66988070.0  HOMBRE       1977-07-12  METROPOLITANO SURORIENTE   \n",
       "\n",
       "  TIPO_INGRESO FECHA_INGRESO  FECHAALTA   TIPOALTA  IR_29301_PESO  \\\n",
       "0     URGENCIA    2023-03-29 2023-04-13  DOMICILIO         1.1263   \n",
       "1     URGENCIA    2023-03-29 2023-04-13  DOMICILIO         1.1263   \n",
       "\n",
       "   IR_29301_SEVERIDAD  IR_29301_MORTALIDAD  EDAD  DIAS_ESTANCIA  \\\n",
       "0                 3.0                  2.0  46.0             15   \n",
       "1                 3.0                  2.0  46.0             15   \n",
       "\n",
       "                                            HOSPITAL  \\\n",
       "0   Complejo Hospitalario Dr. Sótero del Río (San...   \n",
       "1   Complejo Hospitalario Dr. Sótero del Río (San...   \n",
       "\n",
       "                                    DESCCRIPCION_GRD    Versión  \\\n",
       "0   MH DISFUNCIÓN, REACCIÓN O COMPL. POR DISP., I...  CIE-v2013   \n",
       "1   MH DISFUNCIÓN, REACCIÓN O COMPL. POR DISP., I...  CIE-v2013   \n",
       "\n",
       "                              Descripción  \\\n",
       "0  Falla y rechazo de trasplante de riñón   \n",
       "1  Falla y rechazo de trasplante de riñón   \n",
       "\n",
       "                                           Categoría  \\\n",
       "0  T86 FALLA Y RECHAZO DEL TRASPLANTE DE ÓRGANOS ...   \n",
       "1  T86 FALLA Y RECHAZO DEL TRASPLANTE DE ÓRGANOS ...   \n",
       "\n",
       "                                             Sección  \\\n",
       "0  T80-T88  COMPLICACIONES DE LA ATENCIÓN QUIRÚRG...   \n",
       "1  T80-T88  COMPLICACIONES DE LA ATENCIÓN QUIRÚRG...   \n",
       "\n",
       "                                            Capítulo NEXT_FECHA_INGRESO  \\\n",
       "0  Cap.19  LESIONES TRAUMÁTICAS, ENVENENAMIENTOS ...         2023-06-22   \n",
       "1  Cap.19  LESIONES TRAUMÁTICAS, ENVENENAMIENTOS ...         2023-06-22   \n",
       "\n",
       "   DIAS_REINGRESO  READM_7D  READM_30D  READM_60D  READM_90D  PROCEDIMIENTO1  \\\n",
       "0            70.0         0          0          0          1          5523.0   \n",
       "1            70.0         0          0          0          1          9671.0   \n",
       "\n",
       "   PROCEDIMIENTO2  PROCEDIMIENTO3  PROCEDIMIENTO4  PROCEDIMIENTO5  \\\n",
       "0          8703.0          8744.0          8952.0          8875.0   \n",
       "1          9604.0          9396.0          9059.0          8966.0   \n",
       "\n",
       "   PROCEDIMIENTO6  PROCEDIMIENTO7  PROCEDIMIENTO8  PROCEDIMIENTO9  \\\n",
       "0          9039.0          9059.0          8929.0          9132.0   \n",
       "1          8929.0          9132.0          8875.0          9039.0   \n",
       "\n",
       "   PROCEDIMIENTO10  PROCEDIMIENTO11  PROCEDIMIENTO12  PROCEDIMIENTO13  \\\n",
       "0           9139.0           8906.0           8913.0           9318.0   \n",
       "1           9312.0           9318.0           9394.0           9919.0   \n",
       "\n",
       "   PROCEDIMIENTO14  PROCEDIMIENTO15  PROCEDIMIENTO16  PROCEDIMIENTO17  \\\n",
       "0             68.0           3891.0           8966.0            99.21   \n",
       "1            966.0              NaN              NaN              NaN   \n",
       "\n",
       "  PROCEDIMIENTO18  PROCEDIMIENTO19  PROCEDIMIENTO20  PROCEDIMIENTO21  \\\n",
       "0           99.19            99.29              NaN              NaN   \n",
       "1            None              NaN              NaN              NaN   \n",
       "\n",
       "   PROCEDIMIENTO22  PROCEDIMIENTO23  PROCEDIMIENTO24  PROCEDIMIENTO25  \\\n",
       "0              NaN              NaN              NaN              NaN   \n",
       "1              NaN              NaN              NaN              NaN   \n",
       "\n",
       "   PROCEDIMIENTO26  PROCEDIMIENTO27  PROCEDIMIENTO28  PROCEDIMIENTO29  \\\n",
       "0              NaN              NaN              NaN              NaN   \n",
       "1              NaN              NaN              NaN              NaN   \n",
       "\n",
       "   PROCEDIMIENTO30  \n",
       "0              NaN  \n",
       "1              NaN  "
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ruta3 = r'https://github.com/gmarinr/TOPD/raw/refs/heads/main/Archivos/GRD_Completo.parquet' #Correo a brcarom@udd.cl por si no te sirve la ruta\n",
    "df_GRD = pd.read_parquet(ruta3)\n",
    "df_GRD.head(2)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ed29d8f6",
   "metadata": {},
   "source": [
    "# Análisis Descriptivo en función de Sección\n",
    "Para este caso, necesitamos ver cómo distribuyen esos y centrarnos en las secciones que realmente importan "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "3f4b481c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Sección\n",
       "Z40-Z54  CONTACTOS PARA OTRA ATENCIÓN ESPECÍFICA DE SALUD                                         0.148265\n",
       "H25-H28  TRASTORNOS DEL CRISTALINO                                                                0.050613\n",
       "C81-C96  NEOPLASIA MALIGNA DE TEJIDOS LINFOIDE, HEMOPOÝETICO Y RELACIONADOS                       0.033624\n",
       "T80-T88  COMPLICACIONES DE LA ATENCIÓN QUIRÚRGICA Y MÉDICA, NO CLASIFICADAS BAJO OTRO CONCEPTO    0.032944\n",
       "O20-O29  OTROS TRASTORNOS MATERNOS RELACIONADOS PRINCIPALMENTE CON EL EMBARAZO                    0.032774\n",
       "                                                                                                    ...   \n",
       "R47-R49  SÍNTOMAS Y SIGNOS QUE AFECTAN AL HABLA Y A LA VOZ                                        0.000008\n",
       "B90-B94  SECUELAS DE ENFERMEDADES INFECCIOSAS Y PARASITARIAS                                      0.000008\n",
       "B95-B97  AGENTES INFECCIOSOS BACTERIANOS Y VIRALES                                                0.000004\n",
       "A65-A69  OTRAS ENFERMEDADES POR ESPIROQUETAS                                                      0.000003\n",
       "L55-L59  TRASTORNOS DE LA PIEL Y DEL TEJIDO SUBCUTÁNEO RELACIONADOS CON LA RADIACIÓN              0.000003\n",
       "Name: proportion, Length: 228, dtype: float64"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_GRD['Sección'].unique()\n",
    "df_GRD['Sección'].value_counts(normalize=True)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "636cf2ef",
   "metadata": {},
   "source": [
    "# Selección de secciones para el análisis\n",
    "Para centrar nuestro estudio en diagnósticos clínicos bien definidos y con suficiente representación, seguimos estos pasos:  \n",
    "\n",
    "Excluimos secciones administrativas, de seguimiento o síntomas inespecíficos (rangos Z00–Z99, R00–R99, V01–Y98), pues no aportan información sobre un tratamiento concreto ni un cuadro clínico claro.  \n",
    "\n",
    "Priorizamos secciones con un alto volumen de casos y relevancia clínica, quedándonos con aquellas cuyos prefijos corresponden a:  \n",
    "\n",
    "1. H25–H28: Trastornos del cristalino (~5,06 % del total)\n",
    "2. C81–C96: Neoplasias malignas de tejidos linfoide, hemopoyético y relacionados (~3,36 %)\n",
    "3. T80–T88: Complicaciones de la atención quirúrgica y médica (~3,29 %)\n",
    "4. O20–O29: Otros trastornos maternos relacionados principalmente con el embarazo (~3,28 %)\n",
    "  \n",
    "Con esto, enfocamos el análisis descriptivo y predictivo en grupos de alto interés clínico y con muestra suficiente para entrenar modelos robustos."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "e9694be2",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Registros totales tras filtrado: 107013\n"
     ]
    }
   ],
   "source": [
    "# 2) Definimos las secciones objetivo por su prefijo\n",
    "selected_prefixes = ['H25-H28', 'C81-C96', 'T80-T88', 'O20-O29']\n",
    "\n",
    "# 3) Filtramos por aquellas filas cuya 'Sección' comienza con uno de los prefijos\n",
    "mask = df_GRD['Sección'].str.split().str[0].isin(selected_prefixes)\n",
    "df_filtered = df_GRD[mask].copy()\n",
    "\n",
    "# (Opcional) Verificamos cuántos registros quedaron\n",
    "print(f\"Registros totales tras filtrado: {len(df_filtered)}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "ff796a41",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['T80-T88  COMPLICACIONES DE LA ATENCIÓN QUIRÚRGICA Y MÉDICA, NO CLASIFICADAS BAJO OTRO CONCEPTO',\n",
       "       'H25-H28  TRASTORNOS DEL CRISTALINO',\n",
       "       'O20-O29  OTROS TRASTORNOS MATERNOS RELACIONADOS PRINCIPALMENTE CON EL EMBARAZO',\n",
       "       'C81-C96  NEOPLASIA MALIGNA DE TEJIDOS LINFOIDE, HEMOPOÝETICO Y RELACIONADOS'],\n",
       "      dtype=object)"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_filtered['Sección'].unique()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "21cafc5d",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Tasas globales de reingreso:\n",
      "  • READM_7D: 24,474 pacientes (22.87%)\n",
      "  • READM_30D: 64,706 pacientes (60.47%)\n",
      "  • READM_60D: 81,809 pacientes (76.45%)\n",
      "  • READM_90D: 90,819 pacientes (84.87%)\n"
     ]
    }
   ],
   "source": [
    "# Ventanas temporales definidas en el DataFrame\n",
    "window_cols = ['READM_7D', 'READM_30D', 'READM_60D', 'READM_90D']\n",
    "total = len(df_filtered)\n",
    "\n",
    "print(\"Tasas globales de reingreso:\")\n",
    "for w in window_cols:\n",
    "    count = df_filtered[w].sum()\n",
    "    print(f\"  • {w}: {count:,} pacientes ({count/total:.2%})\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "23f1055a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Tasa de READM_30D por sección:\n",
      "  • B90-B94  SECUELAS DE ENFERMEDADES INFECCIOSAS Y PARASITARIAS: 100.00%\n",
      "  • L55-L59  TRASTORNOS DE LA PIEL Y DEL TEJIDO SUBCUTÁNEO RELACIONADOS CON LA RADIACIÓN: 100.00%\n",
      "  • P10-P15  TRAUMATISMO AL NACIMIENTO: 98.07%\n",
      "  • P80-P83  ALTERACIONES QUE AFECTAN A LA PIEL Y LOS ANEJOS Y A LA REGULACIÓN DE LA TEMPERATURA DEL RECIÉN NACIDO: 88.36%\n",
      "  • C40-C41  NEOPLASIAS MALIGNAS DE HUESO Y DE CARTÍLAGO ARTICULAR: 88.33%\n",
      "  • D70-D77  OTROS TRASTORNOS DE LA SANGRE Y DE LOS ÓRGANOS HEMATOPOYÉTICOS: 86.83%\n",
      "  • O00-O08  EMBARAZO CON RESULTADO ABORTIVO: 85.89%\n",
      "  • T29-T32  QUEMADURAS Y CORROSIONES DE REGIONES CORPORALES MÚLTIPLES Y LAS NO ESPECIFICADAS: 84.73%\n",
      "  • C81-C96  NEOPLASIA MALIGNA DE TEJIDOS LINFOIDE, HEMOPOÝETICO Y RELACIONADOS: 84.02%\n",
      "  • Z40-Z54  CONTACTOS PARA OTRA ATENCIÓN ESPECÍFICA DE SALUD: 83.89%\n",
      "  • E70-E88  ALTERACIONES METABÓLICAS: 83.22%\n",
      "  • Q90-Q99  ANOMALÍAS CROMOSÓMICAS, NO CLASIFICADAS BAJO OTRO CONCEPTO: 82.18%\n",
      "  • T14-T14  TRAUMATISMO EN REGIÓN CORPORAL NO ESPECIFICADA: 82.13%\n",
      "  • F99-F99  TRASTORNO MENTAL NO ESPECIFICADO: 81.82%\n",
      "  • O85-O92  COMPLICACIONES PRINCIPALMENTE RELACIONADAS CON PUERPERIO: 81.46%\n",
      "  • O10-O16  EDEMA, PROTEINURIA Y TRASTORNOS HIPERTENSIVOS EN EL EMBARAZO, PARTO Y PUERPERIO: 80.32%\n",
      "  • Z20-Z29  PERSONAS CON RIESGOS POTENCIALES DE SALUD RELACIONADOS CON ENFERMEDADES TRANSMISIBLES: 79.12%\n",
      "  • Z77-Z99  PERSONAS CON RIESGOS POTENCIALES DE SALUD RELACIONADOS CON HISTORIA FAMILIAR Y PERSONAL, Y DETERMINADAS AFECCIONES QUE INFLUYEN EN EL ESTADO DE SALUD: 78.67%\n",
      "  • P35-P39  INFECCIONES ESPECÍFICAS DEL PERÍODO PERINATAL: 77.22%\n",
      "  • D65-D69  ALTERACIONES DE LA COAGULACIÓN, PÚRPURA Y OTRAS AFECCIONES HEMORRÁGICAS: 77.08%\n",
      "  • F20-F29  ESQUIZOFRENIA, TRASTORNO ESQUIZOTÍPICO, TRASTORNO DELIRANTE Y OTROS TRASTORNOS PSICÓTICOS NO RELACIONADOS CON EL ESTADO DE ÁNIMO: 74.93%\n",
      "  • T20-T25  QUEMADURAS Y CORROSIONES DE LA SUPERFICIE CORPORAL EXTERNA, ESPECIFICADAS POR LOCALIZACIÓN: 72.58%\n",
      "  • O60-O77  COMPLICACIONES DEL TRABAJO DE PARTO Y DEL PARTO: 71.17%\n",
      "  • G30-G32  OTRAS ENFERMDADES DEGENERATIVAS DEL SISTEMA NERVIOSO: 70.92%\n",
      "  • B35-B49  MICOSIS: 70.73%\n",
      "  • P90-P96  OTROS TRASTORNOS ORIGINADOS EN EL PERÍODO PERINATAL: 70.67%\n",
      "  • F80-F89  TRASTORNOS GENERALIZADOS Y ESPECÍFICOS DEL DESARROLLO: 70.35%\n",
      "  • C69-C72  NEOPLASIAS MALIGNAS DE OJO, CEREBRO Y OTRAS PARTES DEL SISTEMA NERVIOSO CENTRAL: 68.96%\n",
      "  • Z69-Z76  PERSONAS QUE ENTRAN EN CONTACTO CON LOS SERVICIOS SANITARIOS EN OTRAS CIRCUNSTANCIAS: 68.36%\n",
      "  • C45-C49  NEOPLASIAS MALIGNAS DE TEJIDOS MESOTELIALES Y TEJIDOS BLANDOS: 67.28%\n",
      "  • O30-O48  ATENCIÓN MATERNA RELACIONADA CON EL FETO Y CAVIDAD AMNIÓTICA Y POSIBLES PROBLEMAS EN EL PARTO: 67.24%\n",
      "  • L49-L54  URTICARIA Y ERITEMA: 67.06%\n",
      "  • T08-T13  TRAUMATISMO EN REGIÓN CORPORAL ESPECIFICADA: 67.03%\n",
      "  • B98-B99  OTRAS ENFERMEDADES INFECCIOSAS: 66.67%\n",
      "  • Q30-Q34  MALFORMACIONES CONGÉNITAS DEL APARATO RESPIRATORIO: 65.42%\n",
      "  • Z30-Z39  PERSONAS QUE ENTRAN EN CONTACTO CON LOS SERVICIOS SANITARIOS POR CIRCUNSTANCIAS RELACIONADAS CON LA REPRODUCCIÓN: 64.47%\n",
      "  • A80-A89  INFECCIONES VIRALES Y POR PRIONES DEL SISTEMA NERVIOSO CENTRAL: 63.37%\n",
      "  • J85-J86  ENFERMEDADES SUPURATIVAS Y NECRÓTICAS DEL TRACTO RESPIRATORIO INFERIOR: 62.95%\n",
      "  • Q38-Q45  OTRAS MALFORMACIONES CONGÉNITAS DEL APARATO DIGESTIVO: 62.16%\n",
      "  • B65-B83  HELMINTIASIS: 62.15%\n",
      "  • Q00-Q07  MALFORMACIONES CONGÉNITAS DEL SISTEMA NERVIOSO: 62.08%\n",
      "  • F30-F39  TRASTORNOS DEL ESTADO DE ÁNIMO [AFECTIVOS]: 61.66%\n",
      "  • Q50-Q56  MALFORMACIONES CONGÉNITAS DE LOS ÓRGANOS GENITALES: 61.61%\n",
      "  • M99-M99  LESIONES BIOMECÁNICAS, NO CLASIFICADAS BAJO OTRO CONCEPTO: 61.27%\n",
      "  • D60-D64  ANEMIA APLÁSICA Y OTRAS ANEMIAS Y SÍNDROMES DE INSUFICIENCIA MEDULAR: 61.24%\n",
      "  • B25-B34  OTRAS ENFERMEDADES VIRALES: 60.67%\n",
      "  • N70-N77  ENFERMEDADES INFLAMATORIAS DE LOS ÓRGANOS PÉLVICOS FEMENINOS: 60.55%\n",
      "  • M30-M36  TRASTORNOS SISTÉMICOS DEL TEJIDO CONECTIVO: 59.82%\n",
      "  • P50-P61  TRASTORNOS HEMORRÁGICOS Y HEMATOLÓGICOS DEL RECIÉN NACIDO: 59.63%\n",
      "  • H60-H62  ENFERMEDADES DEL OÍDO EXTERNO: 59.38%\n",
      "  • C51-C58  NEOPLASIAS MALIGNAS DE ÓRGANOS GENITALES FEMENINOS: 59.13%\n",
      "  • R00-R09  SÍNTOMAS Y SIGNOS QUE AFECTAN A LOS APARATOS CIRCULATORIO Y RESPIRATORIO: 59.02%\n",
      "  • S90-S99  TRAUMATISMOS EN TOBILLO Y PIE: 58.98%\n",
      "  • B20-B23  ENFERMEDAD POR VIRUS DE LA INMUNODEFICIENCIA HUMANA [VIH]: 58.63%\n",
      "  • B00-B09  INFECCIONES VIRALES CARACTERIZADAS POR LESIONES DE LA PIEL Y DE LAS MEMBRANAS MUCOSAS: 58.63%\n",
      "  • J00-J06  INFECCIONES AGUDAS DEL TRACTO RESPIRATORIO SUPERIOR: 58.01%\n",
      "  • F40-F48  TRASTORNO DE ANSIEDAD, DISOCIATIVO, RELACIONADO CON ESTRÉS Y OTROS TRASTORNOS MENTALES SOMATOMORFOS NO PSICÓTICOS: 57.98%\n",
      "  • S00-S09  TRAUMATISMOS EN LA CABEZA: 57.91%\n",
      "  • K70-K77  ENFERMEDADES DE HÍGADO: 57.83%\n",
      "  • T15-T19  EFECTOS DE CUERPO EXTRAÑO QUE PENETRA A TRAVÉS DE ORIFICIO NATURAL: 57.71%\n",
      "  • F70-F79  DISCAPACIDAD INTELECTUAL: 57.48%\n",
      "  • F50-F59  SÍNDROMES DE COMPORTAMIENTO ASOCIADOS A TRASTORNOS FISIOLÓGICOS Y FACTORES FÍSICOS: 57.23%\n",
      "  • E50-E64  OTRAS CARENCIAS NUTRICIONALES: 57.14%\n",
      "  • E40-E46  DESNUTRICIÓN: 57.08%\n",
      "  • T26-T28  QUEMADURAS Y CORROSIONES LIMITADAS A OJO Y ÓRGANOS INTERNOS: 56.82%\n",
      "  • Q20-Q28  MALFORMACIONES CONGÉNITAS DEL APARATO CIRCULATORIO: 56.77%\n",
      "  • C30-C39  NEOPLASIAS MALIGNAS DE ÓRGANOS RESPIRATORIOS E INTRATORÁCICOS: 56.73%\n",
      "  • B85-B89  PEDICULOSIS, ACARIASIS Y OTRAS INFESTACIONES: 56.14%\n",
      "  • O20-O29  OTROS TRASTORNOS MATERNOS RELACIONADOS PRINCIPALMENTE CON EL EMBARAZO: 56.07%\n",
      "  • D50-D53  ANEMIAS CARENCIALES: 55.94%\n",
      "  • A30-A49  OTRAS ENFERMEDADES BACTERIANAS: 55.87%\n",
      "  • C76-C80  NEOPLASIAS MALIGNAS DE LOCALIZACIONES MAL DEFINIDAS, OTRAS LOCALIZACIONES SECUNDARIAS Y LOCALIZACIONES NO ESPECIFICADAS: 55.83%\n",
      "  • M40-M43  DORSOPATÍAS DEFORMANTES: 55.56%\n",
      "  • S30-S39  TRAUMATISMOS EN ABDOMEN, PARTE INFERIOR DE ESPALDA, COLUMNA LUMBAR, PELVIS Y GENITALES EXTERNOS: 55.42%\n",
      "  • F90-F98  TRASTORNOS DE CONDUCTA Y TRASTORNOS EMOCIONALES CUYO INICIO SE PRESENTA HABITUALMENTE EN INFANCIA Y ADOLESCENCIA: 55.28%\n",
      "  • B15-B19  HEPATITIS VIRAL: 55.17%\n",
      "  • K35-K38  ENFERMEDADES DEL APÉNDICE: 55.07%\n",
      "  • Z00-Z13  PERSONAS EN CONTACTO CON LOS SERVICIOS SANITARIOS PARA RECONOCIMIENTO MÉDICO: 54.95%\n",
      "  • S80-S89  TRAUMATISMOS EN RODILLA Y PIERNA: 54.94%\n",
      "  • A00-A09  ENFERMEDADES INFECCIOSAS INTESTINALES: 54.87%\n",
      "  • O80-O84  CONTACTO PARA EL PARTO: 54.60%\n",
      "  • J60-J70  ENFERMEDADES PULMONARES POR AGENTES EXTERNOS: 54.58%\n",
      "  • B50-B64  ENFERMEDADES CAUSADAS POR PROTOZOOS: 54.55%\n",
      "  • T00-T07  TRAUMATISMOS QUE AFECTAN A MÚLTIPLES REGIONES CORPORALES: 54.41%\n",
      "  • P19-P29  TRASTORNOS RESPIRATORIOS Y CARDIOVASCULARES ESPECÍFICOS DEL PERÍODO PERINATAL: 54.40%\n",
      "  • H25-H28  TRASTORNOS DEL CRISTALINO: 54.17%\n",
      "  • K00-K14  ENFERMEDADES DE LA CAVIDAD ORAL Y GLÁNDULAS SALIVALES: 54.05%\n",
      "  • S40-S49  TRAUMATISMOS EN HOMBRO Y  BRAZO: 54.02%\n",
      "  • D37-D48  NEOPLASIAS DE COMPORTAMIENTO INCIERTO, POLICITEMIA VERA Y SÍNDROMES MIELODISPLÁSICOS: 53.79%\n",
      "  • R10-R19  SÍNTOMAS Y SIGNOS QUE AFECTAN AL APARATO DIGESTIVO Y EL ABDOMEN: 53.54%\n",
      "  • E00-E07  TRASTORNOS DE GLÁNDULA TIROIDES: 53.10%\n",
      "  • C60-C63  NEOPLASIAS MALIGNAS DE ÓRGANOS GENITALES MASCULINOS: 52.68%\n",
      "  • Q80-Q89  OTRAS MALFORMACIONES CONGÉNITAS: 52.58%\n",
      "  • S10-S19  TRAUMATISMOS EN EL CUELLO: 52.55%\n",
      "  • G00-G09  ENFERMEDADES INFLAMATORIAS DEL SISTEMA NERVIOSO CENTRAL: 52.29%\n",
      "  • D10-D36  TUMORES BENIGNOS, EXCEPTO TUMORES NEUROENDOCRINOS BENIGNOS: 52.14%\n",
      "  • I05-I09  ENFERMEDADES REUMÁTICAS CRÓNICAS CARDIACAS: 51.88%\n",
      "  • M45-M49  ESPONDILOPATÍAS: 51.74%\n",
      "  • S60-S69  TRAUMATISMOS EN MUÑECA, MANO Y DEDOS: 51.62%\n",
      "  • I70-I79  ENFERMEDADES DE ARTERIAS, ARTERIOLAS Y CAPILARES: 51.56%\n",
      "  • M05-M14  POLIARTROPATÍAS INFLAMATORIAS: 51.50%\n",
      "  • J20-J22  OTRAS INFECCIONES AGUDAS DEL TRACTO RESPIRATORIO INFERIOR: 51.43%\n",
      "  • R25-R29  SÍNTOMAS Y SIGNOS QUE INVOLUCRAN LOS SISTEMAS NERVIOSO Y APARATO MUSCULOESQUELÉTICO: 51.35%\n",
      "  • J90-J94  OTRAS ENFERMEDADES DE LA PLEURA: 51.30%\n",
      "  • J96-J99  OTRAS ENFERMEDADES DEL APARATO RESPIRATORIO: 51.03%\n",
      "  • R50-R69  SÍNTOMAS Y SIGNOS GENERALES: 50.91%\n",
      "  • K65-K68  ENFERMEDADES DEL PERITONEO Y RETROPERITONEO: 50.86%\n",
      "  • O94-O9A  OTRAS AFECCIONES OBSTÉTRICAS NO CLASIFICADAS BAJO OTRO CONCEPTO: 50.81%\n",
      "  • M00-M03  ARTROPATÍAS INFECCIOSAS: 50.71%\n",
      "  • A15-A19  TUBERCULOSIS: 50.71%\n",
      "  • I26-I28  ENFERMEDAD PULMONAR CARDIACA Y ENFERMEDADES DE LA CIRCULACIÓN PULMONAR: 50.56%\n",
      "  • N40-N53  ENFERMEDADES DE LOS ÓRGANOS GENITALES MASCULINOS: 50.49%\n",
      "  • T80-T88  COMPLICACIONES DE LA ATENCIÓN QUIRÚRGICA Y MÉDICA, NO CLASIFICADAS BAJO OTRO CONCEPTO: 50.48%\n",
      "  • L20-L30  DERMATITIS Y ECCEMA: 50.38%\n",
      "  • D80-D89  ALGUNOS TRASTORNOS QUE AFECTAN AL MECANISMO INMUNITARIO: 50.33%\n",
      "  • S20-S29  TRAUMATISMOS EN EL TÓRAX: 50.29%\n",
      "  • I20-I25  ENFERMEDADES ISQUÉMICAS CARDIACAS: 50.21%\n",
      "  • U00-U49  ASIGNACION PROVISIONAL DE NUEVAS ENFERMEDADES DE ETIOLOGIA INCIERTA: 50.17%\n",
      "  • C64-C68  NEOPLASIAS MALIGNAS DE TRACTO URINARIO: 50.11%\n",
      "  • R83-R89  RESULTADOS ANORMALES EN ANÁLISIS DE OTROS LÍQUIDOS CORPORALES, SUSTANCIAS Y TEJIDOS, SIN DIAGNÓSTICO: 50.00%\n",
      "  • R90-R94  HALLAZGOS ANORMALES EN DIAGNÓSTICO POR IMAGEN Y EN ESTUDIOS FUNCIONALES, SIN DIAGNÓSTICO: 50.00%\n",
      "  • M91-M94  CONDROPATÍAS: 50.00%\n",
      "  • K80-K87  TRASTORNOS DE LA VESÍCULA BILIAR, VÍAS BILIARES Y PÁNCREAS: 49.95%\n",
      "  • G89-G99  OTROS TRASTORNOS DEL SISTEMA NERVIOSO: 49.46%\n",
      "  • G80-G83  PARÁLISIS CEREBRAL Y OTROS SÍNDROMES PARALÍTICOS: 49.40%\n",
      "  • Z55-Z65  PERSONAS CON RIESGOS POTENCIALES DE SALUD RELACIONADOS CON SU SITUACIÓN SOCIOECONÓMICA Y PSICOSOCIAL: 49.32%\n",
      "  • N00-N08  ENFERMEDADES GLOMERULARES: 49.10%\n",
      "  • E89-E90  COMPLICACIONES Y TRASTORNOS ENDOCRINOS Y METABÓLICOS POSPROCEDIMIENTO, NO CLASIFICADOS BAJO OTRO CONCEPTO: 48.89%\n",
      "  • K50-K52  ENTERITIS Y COLITIS NO INFECCIOSAS: 48.88%\n",
      "  • N99-N99  COMPLICACIONES Y TRASTORNOS INTRAOPERATORIOS Y POSPROCEDIMIENTO DE APARATO GENITOURINARIO, NO CLASIFICADOS BAJO OTRO CONCEPTO: 48.83%\n",
      "  • J09-J18  GRIPE Y NEUMONÍA: 48.56%\n",
      "  • R40-R46  SÍNTOMAS Y SIGNOS QUE AFECTAN A LAS FUNCIONES COGNITIVAS, A LA PERCEPCIÓN, AL ESTADO EMOCIONAL Y A LA CONDUCTA: 48.45%\n",
      "  • C15-C26  NEOPLASIAS MALIGNAS DE ÓRGANOS DIGESTIVOS: 48.28%\n",
      "  • R70-R79  RESULTADOS ANORMALES EN ANALISIS DE SANGRE, SIN DIAGNÓSTICO: 48.00%\n",
      "  • D55-D59  ANEMIAS HEMOLÍTICAS: 47.98%\n",
      "  • R30-R39  SÍNTOMAS Y SIGNOS QUE AFECTAN AL APARATO GENITOURINARIO: 47.88%\n",
      "  • M60-M63  TRASTORNOS DE LOS MÚSCULOS: 47.73%\n",
      "  • K55-K64  OTRAS ENFERMEDADES DE LOS INTESTINOS: 47.06%\n",
      "  • J30-J39  OTRAS ENFERMEDADES DEL TRACTO RESPIRATORIO SUPERIOR: 47.03%\n",
      "  • S50-S59  TRAUMATISMOS EN CODO Y ANTEBRAZO: 46.82%\n",
      "  • C00-C14  NEOPLASIAS MALIGNAS DE LABIO, CAVIDAD ORAL Y FARINGE: 46.78%\n",
      "  • J40-J47  ENFERMEDADES CRÓNICAS DEL TRACTO RESPIRATORIO INFERIOR: 46.66%\n",
      "  • N80-N98  TRASTORNOS NO INFLAMATORIOS DEL TRACTO GENITAL FEMENINO: 46.53%\n",
      "  • T66-T78  OTROS EFECTOS Y LOS NO ESPECIFICADOS DE CAUSAS EXTERNAS: 46.46%\n",
      "  • L80-L99  OTROS TRASTORNOS DE LA PIEL Y DEL TEJIDO SUBCUTÁNEO: 46.33%\n",
      "  • P00-P04  RECIÉN NACIDO AFECTADO POR FACTORES MATERNOS Y POR COMPLICACIONES DEL EMBARAZO, TRABAJO DE PARTO Y PARTO: 46.31%\n",
      "  • G40-G47  TRASTORNOS EPISÓDICOS Y PAROXÍSTICOS: 46.19%\n",
      "  • J95-J95  COMPLICACIONES Y TRASTORNOS INTRAOPERATORIOS Y POSPROCEDIMIENTO DE APARATO RESPIRATORIO, NO CLASIFICADOS BAJO OTRO CONCEPTO: 46.15%\n",
      "  • K90-K95  OTRAS ENFERMEDADES DEL APARATO DIGESTIVO: 46.12%\n",
      "  • F60-F69  TRASTORNOS DE PERSONALIDAD Y COMPORTAMIENTO DEL ADULTO: 46.00%\n",
      "  • N25-N29  OTROS TRASTORNOS DEL RIÑÓN Y URÉTER: 45.95%\n",
      "  • N30-N39  OTRAS ENFERMEDADES DEL APARATO URINARIO: 45.89%\n",
      "  • T90-T98  SECUELAS DE TRAUMATISMOS, DE ENVENENAMIENTOS Y DE OTRAS CONSECUENCIAS DE CAUSAS EXTERNAS: 45.87%\n",
      "  • K20-K31  ENFERMEDADES DEL ESÓFAGO, ESTÓMAGO Y DUODENO: 45.76%\n",
      "  • S70-S79  TRAUMATISMOS EN CADERA Y MUSLO: 45.44%\n",
      "  • J80-J84  OTRAS ENFERMEDADES RESPIRATORIAS QUE AFECTAN PRINCIPALMENTE AL INTERSTICIO: 45.42%\n",
      "  • I95-I99  OTROS TRASTORNOS DE APARATO CIRCULATORIO Y LOS NO ESPECIFICADOS: 45.38%\n",
      "  • E20-E35  TRASTORNOS DE OTRAS GLÁNDULAS ENDOCRINAS: 44.92%\n",
      "  • K40-K46  HERNIA: 44.88%\n",
      "  • T79-T79  CIERTAS COMPLICACIONES PRECOCES DE TRAUMATISMOS: 44.67%\n",
      "  • H65-H75  ENFERMEDADES DEL OIDO MEDIO Y MASTOIDES: 44.49%\n",
      "  • H53-H54  ALTERACIONES VISUALES Y CEGUERA: 44.44%\n",
      "  • P70-P75  TRASTORNOS ENDOCRINOS Y METABÓLICOS TRANSITORIOS ESPECÍFICOS DEL RECIÉN NACIDO: 44.40%\n",
      "  • M96-M96  COMPLICACIONES Y TRASTORNOS INTRAOPERATORIOS Y POSPROCEDIMIENTO DEL APARATO MUSCULOESQUELÉTICO, NO CLASIFICADOS BAJO OTRO CONCEPTO: 44.30%\n",
      "  • E08-E14  DIABETES MELLITUS: 44.26%\n",
      "  • M95-M95  OTROS TRASTORNOS DEL APARATO MUSCULOESQUELÉTICO Y DEL TEJIDO CONECTIVO: 44.26%\n",
      "  • L00-L08  INFECCIONES DE LA PIEL Y DEL TEJIDO SUBCUTÁNEO: 44.19%\n",
      "  • M86-M90  OTRAS OSTEOPATÍAS: 43.64%\n",
      "  • H15-H22  TRASTORNOS DE ESCLERÓTICA, CÓRNEA, IRIS Y CUERPO CILIAR: 43.52%\n",
      "  • H90-H94  OTROS TRASTORNOS DEL OÍDO: 43.48%\n",
      "  • I30-I52  OTRAS FORMAS DE ENFERMEDAD CARDIACA: 43.29%\n",
      "  • F10-F19  TRASTORNOS MENTALES Y DEL COMPORTAMIENTO DEBIDOS AL CONSUMO DE SUSTANCIAS PSICOACTIVAS: 43.29%\n",
      "  • N10-N16  ENFERMEDADES RENALES TÚBULO-INTERSTICIALES: 43.24%\n",
      "  • Q65-Q79  MALFORMACIONES Y DEFORMIDADES CONGÉNITAS DEL APARATO MUSCULOESQUELÉTICO: 42.69%\n",
      "  • M80-M85  TRASTORNOS DE DENSIDAD Y ESTRUCTURA ÓSEAS: 42.61%\n",
      "  • P76-P78  TRASTORNOS DEL APARATO DIGESTIVO DEL RECIÉN NACIDO: 42.55%\n",
      "  • I60-I69  ENFERMEDADES CEREBROVASCULARES: 42.48%\n",
      "  • F00-F09  TRASTORNOS MENTALES DEBIDOS A AFECCIONES FISIOLÓGICAS CONOCIDAS: 42.45%\n",
      "  • N17-N19  FALLO RENAL AGUDO Y ENFERMEDAD RENAL CRÓNICA: 42.40%\n",
      "  • N20-N23  LITIASIS URINARIA: 42.28%\n",
      "  • H46-H48  TRASTORNOS DE NERVIO ÓPTICO Y VÍAS VISUALES: 42.02%\n",
      "  • I10-I16  ENFERMEDADES HIPERTENSIVAS: 41.97%\n",
      "  • C43-C44  MELANOMA Y OTRAS NEOPLASIAS MALIGNAS DE PIEL: 41.78%\n",
      "  • E15-E16  OTROS TRASTORNOS DE LA REGULACIÓN DE LA GLUCOSA Y DE LA SECRECIÓN INTERNA DEL PÁNCREAS: 41.65%\n",
      "  • P05-P08  TRASTORNOS DEL RECIÉN NACIDO RELACIONADOS CON LA DURACIÓN DE LA GESTACIÓN Y EL CRECIMIENTO FETAL: 40.18%\n",
      "  • G70-G73  ENFERMEDADES DE LA UNIÓN NEUROMUSCULAR Y DEL MÚSCULO: 40.16%\n",
      "  • T36-T50  ENVENENAMIENTO, EFECTO ADVERSO E INFRADOSIFICACIÓN DE FÁRMACOS, MEDICAMENTOS Y SUSTANCIAS BIOLÓGICAS: 39.92%\n",
      "  • M65-M68  TRASTORNOS DE MEMBRANA SINOVIAL Y TENDONES: 39.83%\n",
      "  • R20-R23  SÍNTOMAS Y SIGNOS QUE AFECTAN A LA PIEL Y AL TEJIDO CELULAR SUBCUTÁNEO: 39.53%\n",
      "  • Q10-Q18  MALFORMACIONES CONGÉNITAS DE LOS OJOS, OÍDOS, CARA Y CUELLO: 39.42%\n",
      "  • T51-T65  EFECTOS TÓXICOS DE SUSTANCIAS DE PROCEDENCIA PRINCIPALMENTE NO MEDICAMENTOSA: 39.19%\n",
      "  • Q60-Q64  MALFORMACIONES CONGÉNITAS DEL APARATO URINARIO: 39.09%\n",
      "  • E65-E68  SOBREPESO, OBESIDAD Y OTROS TIPOS DE HIPERALIMENTACIÓN: 38.46%\n",
      "  • N60-N65  TRASTORNOS DE LA MAMA: 38.33%\n",
      "  • M50-M54  OTRAS DORSOPATÍAS: 37.80%\n",
      "  • C73-C75  NEOPLASIAS MALIGNAS DE TIROIDES Y OTRAS GLÁNDULAS ENDOCRINAS: 37.79%\n",
      "  • L60-L75  TRASTORNOS DE LOS ANEJOS CUTÁNEOS: 37.79%\n",
      "  • H00-H06  TRASTORNOS DE PÁRPADO, APARATO LACRIMAL Y ÓRBITA: 37.48%\n",
      "  • G35-G37  ENFERMEDADES DESMIELINIZANTES DEL SISTEMA NERVIOSO CENTRAL: 36.82%\n",
      "  • M15-M19  ARTROSIS: 36.50%\n",
      "  • H59-H59  COMPLICACIONES Y TRASTORNOS INTRAOPERATORIOS Y POSPROCEDIMIENTO DE OJO Y SUS ANEXOS, NO CLASIFICADOS BAJO OTRO CONCEPTO: 36.50%\n",
      "  • M70-M79  OTROS TRASTORNOS DE PARTES BLANDAS: 36.18%\n",
      "  • H40-H42  GLAUCOMA: 35.64%\n",
      "  • I80-I89  ENFERMEDADES DE VENAS, VASOS Y GANGLIOS LINFÁTICOS, NO CLASIFICADAS BAJO OTRO CONCEPTO: 35.52%\n",
      "  • A50-A64  INFECCIONES CON MODO DE TRANSMISIÓN PREDOMINANTEMENTE SEXUAL: 33.70%\n",
      "  • H95-H95  COMPLICACIONES Y TRASTORNOS INTRAOPERATORIOS Y POSPROCEDIMIENTO DEL OÍDO Y APÓFISIS MASTOIDES, NO CLASIFICADOS BAJO OTRO CONCEPTO: 33.33%\n",
      "  • G60-G65  POLINEUROPATÍAS Y OTROS TRASTORNOS DEL SISTEMA NERVIOSO PERIFÉRICO: 32.65%\n",
      "  • G20-G26  TRASTORNOS EXTRAPIRAMIDALES Y DEL MOVIMIENTO: 32.60%\n",
      "  • C97  NEOPLASIAS MALIGNAS DE MÚLTIPLES LOCALIZACIONES INDEPENDIENTES: 31.71%\n",
      "  • Q35-Q37  LABIO LEPORINO Y PALADAR HENDIDO: 30.96%\n",
      "  • M20-M25  OTROS TRASTORNOS DE ARTICULACIÓN: 30.50%\n",
      "  • H80-H83  ENFERMEDADES DEL OÍDO INTERNO: 29.60%\n",
      "  • G10-G14  ATROFIAS SISTÉMICAS QUE AFECTAN PRINCIPALMENTE AL SISTEMA NERVIOSO CENTRAL: 28.43%\n",
      "  • H55-H58  OTROS TRASTORNOS DEL OJO Y SUS ANEXOS: 26.42%\n",
      "  • H43-H45  TRASTORNOS DE CUERPO VÍTREO Y GLOBO OCULAR: 25.67%\n",
      "  • H10-H13  TRASTORNOS DE CONJUNTIVA: 25.44%\n",
      "  • C50-C50  NEOPLASIAS MALIGNAS DE MAMA: 23.37%\n",
      "  • H30-H36  TRASTORNOS DE COROIDES Y RETINA: 21.80%\n",
      "  • L40-L45  TRASTORNOS PAPULOESCAMOSOS: 21.62%\n",
      "  • D00-D09  NEOPLASIAS IN SITU: 20.71%\n",
      "  • H49-H52  TRASTORNOS DE MÚSCULOS OCULARES, MOVIMIENTO BINOCULAR, ACOMODACIÓN Y REFRACCIÓN: 19.93%\n",
      "  • G50-G59  TRASTORNOS DE LOS NERVIOS, DE LAS RAÍCES Y DE LOS PLEXOS NERVIOSOS: 18.00%\n",
      "  • L10-L14  TRASTORNOS AMPOLLOSOS: 16.67%\n",
      "  • A65-A69  OTRAS ENFERMEDADES POR ESPIROQUETAS: 0.00%\n",
      "  • I00-I02  FIEBRE REUMÁTICA AGUDA: 0.00%\n",
      "  • A20-A28  CIERTAS ZOONOSIS BACTERIANAS: 0.00%\n",
      "  • B95-B97  AGENTES INFECCIOSOS BACTERIANOS Y VIRALES: 0.00%\n",
      "  • R47-R49  SÍNTOMAS Y SIGNOS QUE AFECTAN AL HABLA Y A LA VOZ: 0.00%\n"
     ]
    }
   ],
   "source": [
    "# 3) Tasa READM_30D por sección\n",
    "tasa_sec = df_GRD.groupby('Sección')['READM_30D'].mean().sort_values(ascending=False)\n",
    "print(\"\\nTasa de READM_30D por sección:\")\n",
    "for sec, val in tasa_sec.items():\n",
    "    print(f\"  • {sec}: {val*100:.2f}%\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "0f3f53ab",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Distribución de DIAS_REINGRESO (pacientes con READM_30D == 1):\n",
      "count    64706\n",
      "mean        12\n",
      "std          8\n",
      "min          1\n",
      "25%          6\n",
      "50%         11\n",
      "75%         18\n",
      "max         30\n",
      "Name: DIAS_REINGRESO, dtype: int64\n"
     ]
    }
   ],
   "source": [
    "# Solo pacientes que reingresaron al menos una vez\n",
    "reingresados = df_filtered[df_filtered['READM_30D'] == 1]\n",
    "\n",
    "# Estadísticas básicas de DIAS_REINGRESO\n",
    "desc = reingresados['DIAS_REINGRESO'].describe().astype(int)\n",
    "print(\"\\nDistribución de DIAS_REINGRESO (pacientes con READM_30D == 1):\")\n",
    "print(desc)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "c6843008",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "DIAS_REINGRESO – estadísticos clave:\n",
      "count    420507.0\n",
      "mean         11.3\n",
      "std           8.4\n",
      "min           1.0\n",
      "25%           4.0\n",
      "50%           9.0\n",
      "75%          17.0\n",
      "max          30.0\n",
      "Name: DIAS_REINGRESO, dtype: float64\n"
     ]
    }
   ],
   "source": [
    "reing = df_GRD[df_GRD['READM_30D']==1]\n",
    "print(\"\\nDIAS_REINGRESO – estadísticos clave:\")\n",
    "print(reing['DIAS_REINGRESO'].describe().round(1))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "d93aa8f2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAkQAAAHHCAYAAABeLEexAAAAOnRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjEwLjMsIGh0dHBzOi8vbWF0cGxvdGxpYi5vcmcvZiW1igAAAAlwSFlzAAAPYQAAD2EBqD+naQAASqJJREFUeJzt3Qd4FOX69/GbUJIAAhJKQKqCNCkCgogiCNI9IOgBBaniH0SUInBQmhRBqqgIClIsSDkCCkqTXqUIipQIggalCVIMJQlh3ut+zjX77iabQrKym8z3c13Dsjuzs8/OTrK/PG0yWZZlCQAAgIMF+bsAAAAA/kYgAgAAjkcgAgAAjkcgAgAAjkcgAgAAjkcgAgAAjkcgAgAAjkcgAgAAjkcgAgAAjkcgApJQokQJ6dSpk7+L4UgcewC3E4EIjjFnzhzJlCmT7N692+v6unXryn333Zfm1/nmm29k+PDhad4PfEs/X/38dQkKCpJcuXJJmTJl5LnnnpM1a9YkGsqaN2/udd3FixclJCTE7O/QoUOJvu6yZcvk0UcflQIFCkj27Nnl7rvvln//+9+ycuXKVJdfl9DQUKlUqZK8/fbbcvPmTY9tf/31V49t4y9jx45N8rzX963b9erVK0E5NmzYYNb997//TbDu+PHj8tJLL8m9995r3qsu5cuXl549e8qPP/7osa3+jLiXKWvWrOZ1X375ZXNs47PL5G1p3Lixx7ZbtmyRJk2ayF133WU+o2LFiskTTzwh8+bNS7DfK1euyMiRI82x1PLmzp1bHnnkEfn444+FK1s5SxZ/FwAIZBEREebL81YD0dSpUwlFAahIkSIyZswY1xfh0aNHZfHixfLpp5+akKK3+sWcEosWLTJfxuHh4fLZZ5/JqFGjEmwzYcIE6d+/vwlEgwYNMl+4+prffvutzJ8/P8EX+a2U/9y5c+YLvk+fPvLnn3/K6NGjE2z/zDPPSNOmTRM8fv/996fo9WbMmGHKXbhw4WS3Xb58ubRp00ayZMki7dq1k8qVK5ufncOHD5tjPG3aNBOYihcv7vE8fTxnzpzm81i7dq28++678v3335tQE1+VKlWkX79+CR53L59+LloO3faVV16RO++807zupk2bzPt59tlnXdueOXNG6tevbwJt27ZtTZi7fv26fPHFF9KxY0fzs6yfbebMmVN0vJDO6cVdASeYPXu2/rln7dq1y+v6Rx991KpQoUKaX6dnz57mdfwlKirKygiKFy9udezY0Wf7S+zzvXHjhvXiiy+az2zAgAEJytCsWTOv+6tTp47VqlUrq0+fPlbJkiUTrI+NjbVy5cplPf74416ff+bMmTSX/9q1a6aMd9xxh3kftuPHj5v3M378+FTtV/epj2XJksXq1auXx7r169ebfS9atMj12NGjR60cOXJY5cqVs06ePOn1WEyZMsWKjIx0PTZs2DCznz///NNj2zZt2pjHv/vuuxR/Fu7Kly9vyh4dHZ3sMW/UqJEVFBRkffnllwm2ffXVV005xo4dm+xrImOgyQy4hX4ssbGx8sYbb0jp0qVNVXxYWJg8/PDDriYX3VZrh5R7lb5N/wrWv3CLFi0qwcHBpslGaxHiV81fu3bNNB3ky5dP7rjjDvnXv/4lf/zxh9mXe82T3exw8OBB85ev/jWs5VHaRKHl0SYaLavWZHTp0kXOnz/v8Vr2Pn7++Wdp3769aTLInz+/DBkyxJTrxIkT0qJFC9PEpPuYOHGix/NjYmJk6NChUq1aNfPcHDlymCaH9evXp+gY62to7YrWfmgNSr169eTAgQNet9WmlN69e7uOX6lSpeStt95K0GR0K/Sv/3feecc07bz33nty6dKlZJ8TGRkpmzdvNrUKumgNxLZt2zy20Rqcy5cvS+3atb3uQ5vQ0ko/1wceeED+/vtvOXv2rPj63O/QoYOpVTl58mSS244bN86c27Nnz5ZChQolWK+1Rno+6+eWHD131C+//JKqcuvz9Jhky5YtyWO+Y8cOWbVqlfkZ0Z+v+LQmTn/O9fzSn0dkfAQiOI5+4emXVfxFw05yNDxoINIvbf3yfP31103/BK3iV//3f/8njz/+uPn/J5984lrsL379xTt58mTTVDJp0iQTiLRJpW/fvh6vo7+ktelAmzv0F7L2F2nWrFmi5Xr66afl6tWr8uabb0q3bt3MYxrSjh07Jp07dzb70i9ubabRfXrrG6HNDBostH9JzZo1TUjR/in6frQvhpZDA8irr75qmh9s+qU/c+ZM0xdFt9FjpE04jRo1kn379iV7TDVMafjSJpbx48ebANewYUPzBetO3582PWmzln5Ra4jRsKFNOvGPX2pCkTYv6Wt4a6qJ7/PPPzfBT/sX1ahRQ+655x7TtBL/y1c/N+1D9Ndff8k/xe4vlCdPngTr9P14O9dv3LiRon3r+a3buvc5Sqy5TM8NPW988X6Uhvv49GfU2/txDyzaJKdNb7///nuSr6Ofi9JzyRsNcfpHxoULF2Tr1q1pfFdIF/xdRQXc7iazpBZvTQfuzTaVK1dOtto+sSazpUuXmsdHjRrl8fhTTz1lZcqUyTQ7qD179pjtevfu7bFdp06dzOPa1BC/2eGZZ55J8HpXr15N8Njnn39utt+0aVOCfbzwwguux7T5pUiRIqZc7k0GFy5csEJDQz2OiW4bv3lCtytYsKDVpUuXJI6UZZ09e9bKli2bOaY3b950Pf7aa6+ZMrm/zsiRI02zzM8//+yxj//85z9W5syZPZpjUtMkumTJEvOa2rSTXDNNxYoVrXbt2nmUN1++fKZpyN3QoUPNPrXcTZo0sUaPHm0+39TQ8pctW9Y0Mely+PBhq3///mb/8ctoN5kltmzfvj3J4+L+vjt37myFhIS4msLiN5ldunTJ3G/ZsmWCMut5YJdXF/dz0j7vIiIizLpff/3VmjVrljm/8ufPb125ciVBmRJ7P2PGjHFt99FHH5nH9LyqV6+eNWTIEGvz5s1WXFycx/60vLqdljExixcvNtu88847yXw6yAioIYLjaJOW1p7EX3SUSXL0r3Btzjly5Mgtv6520NSaCG06cKdNaFpjs2LFCnPfHn304osvemznbcSPrXv37gke09oJm3YU1b+kH3zwQXPfrtFy9/zzz7v+r+WsXr26KVfXrl093r/WamnNk/u2dvOE1jBpbYjWKujzvb2OO+1crE1u+t7cmxa1WSw+7SyrzSlac+BeO9CgQQOJi4vzqLVKDe3Yq7T5KSnaFLl//35To2TT/2tZtAnGndYmasdn7cSs67TGRZsWq1atmuTItMRoB2VtztSlbNmypkZNax11BKU3L7zwgtdzXZsHU2rw4MFJ1hJpDaH78XOntYZ2eXWxm5Pd6fmk67SJTpt0taZJfxa0+TQ+rYHy9n7cPwvdh/4M6WtrbZ+OINPzRpu/3Js17c9Zm6QTY6+z3yMyNkaZwXG0iUO/rOOzv2iTMmLECNOfRocV61BlbfrSYdspCVO//fabGQ0T/xdwuXLlXOvtWx2dU7JkSY/t9IsiMfG3VRpM9AtZm8ni9y/x1k9Gm/7caX8g7aOi/ZjiPx6/H9LcuXNN3yL9wnZvevRWLnf2e9YvK3f6BRm/yURDqIYRXedNWvvQREVFJfsFqbTJTpvLtGlPR4wpPU76ha7NZvGbNvXLWhf9Uv3uu+9MeNGQpMPAf/rpJ/PclNLX0D49Gjy1r4yOLNPmycT2ocdVA2Na6PvUc/zDDz+U//znPwnW28fLPn7uPvjgAxM8dDSX9k/zRkd0af80fR/aDKr9sdzDvDs9F1PyfrS5VhdtMtyzZ48sWLBApk+fbpo49RzV5ky73Fo+b82N9jr394iMjUAE3II6deqYL6Ivv/xSVq9ebfrOaJ8g/WXrXsNyu3n7AtFh5PoXsfZR0iHI+he8fpFqiPPWCdnb0OLEhhu790HSgKB9nlq2bGleS79s9HnaKTW1HWO90TJrf6YBAwZ4Xa8hNS00nCQXPPV9a/8h7d/krZZFQ5kGA2+1Jfqlr+XXRYf2a4jUgKT9olJKg5h7INA+VFrb9Nprr5kw8U/Rmi3tC6d9xPRzjh+QtSO1ffzc2X2K7H5Bif1M2aFbQ2LFihXNsH0NMrc65UV8WsuktUO66GvoHwha+6RD6vUPkaVLl5qQrWXwxp476VZq1JB+0WQG3KK8efOajsr6xagjsLR2yH3kl3vTjzvt7KmjdeI3yehfrPZ6+1a//PUvZXd2bURKaEdQ7Viqf9Hrl8CTTz5pvoj1r31f0wn6dL8614zWJOhf5vqlrc10ybHfc/wmSK0t0PfgTjsua9jQfXtb4tdw3QptctNaG/0CtUfpebNx40bTWVdrCrUJz33RGhStkdAv2eTYNZSnTp2StNBzT2tetCZGR779U/TY26/jrcxaK6bn586dO9P0Ohokhw0bZjrjL1y4UHwp/jG3J9zUCRiTOie0pjKxkYLIWAhEwC2I31Skv8C1RiE6Otrjr3gVf7ZdHd2lv2R1dJo7rWHSEKUz6yoNFOr999/32E5HiqWUXbMTfzSZjhrzNW+vpTUf27dvT/a5GmS0tkTfm/vzvZVTa7x0n/H76djHOqUjp+LTz0T7dWmfHr3Vmpzkmsu0Juypp57yWHR0nzZR2aPNNBwldgzs/mLafyattMZMmyl11OI/SfsS6evoEHtvZdAwqf13tHksvluZ8Vlrh3QKBq2NSg39QyCxPnzux/yhhx4y559OFaCj5LzViulUFPreEmvCQ8ZCkxlwC7TqXDtrasdYrSnSy4BoDYnOcGvTdUq/XDXcaGDQIe/aHKDD9fUXrTYh6DBzbXbT5jftRKx/hdvPb926tQkFGsC0I7TWTOgv56RqoNzpl7o2A+iXl36J6bB5fa34tU6+oH9pa+2Q1kJpTYG+hjYh6rHy1q/EnfYH0mH82rym+9HQuHfvXhMY4vdd0hDy1Vdfme20iU6PkzZdaQdn/Qz0mMZ/Tnzad0pDjR1Y7JmqtWlPPyPtgJsYDb3a30Vr2hLrs6MdnKdMmWKazrS5R7909fPTZkqdg0eDm9Yg6RxG2vSU0hmjk6LHWY+bNt/q9AU6N5ZNO7Xb79ednmu1atVKVS2RNvXFp0FQa1O0r5QGDnumag1Cej7oOj0eGnSSowFZZ5jWz1s7R7vP5q1zcXl7P/qHid2Up338tO+a/rxpmfUc0c77Osxe5yfSx21aO6QzVetzdIi9Nq3p56znhF6iRKei0HLAIfw9zA0I5Jmq4w+71yHzNWrUsPLkyWOGB+swaB1KHRMT4zEMXWf31aHDOmzd/cfs77//NjMbFy5c2MqaNatVunRpM5uw+5BzpUOOdfh+3rx5rZw5c5ohwjo8Of7MuYnN9qt+//1368knnzRlzZ07t/X000+bodOJDd2Pvw993zpcPLnjpGV/8803zbEKDg627r//fmv58uXm+fpYcnQ49BtvvGEVKlTIHNO6detaP/30k9eZqvX4DRo0yCpVqpQZVq1D3R966CFrwoQJHp+BN1pu96Haelz1+Ldv395avXq11+e4Dz//4osvzPN0WHdiNmzY4Bq6r0PwZ8yYYT47+9hkz57dHB/9zL3NpJzaaQPs17U/1+SG3bsf1+SG3bs7cuSImeIg/kzVNp06okePHubz0aH69s9I9+7drX379nlsm9S5q0P59ZzVsrmXKbH3436e6dQSbdu2te655x7z+loOnb369ddfty5fvpzgtfScGj58uDkGur3O+l27dm1rzpw5CX4ukbFl0n/8HcoAJE/7VWiNgv6FrH+BAwB8hz5EQADydqkAbULTZofERsQAAFKPPkRAANK+PzrsWPsc6SUEtE+NLjrRXkquB4X0Q0fUacfuxOikl9pfDcA/iyYzIADp7Ls6XF4v2qodk3VIuQ5p1w7ZGpCQcehki/YEld7oPEXawRfAP4tABAB+pBcOTepq6joPjj1yEcA/h0AEAAAcj07VAADA8eiMkAJ6GQW95IJe4C8lk+IBAAD/00YwvVySXlg7uWvjEYhSQMMQI3sAAEif9LqTyc2UTiBKAa0Zsg9oUtc5AgAAgePy5cumQsP+Hk8KgSgF7GYyDUMEIgAA0peUdHehUzUAAHA8AhEAAHA8AhEAAHA8AhEAAHA8AhEAAHA8AhEAAHA8AhEAAHA8AhEAAHA8AhEAAHA8vwaiEiVKmNkj4y89e/Y0669fv27+HxYWJjlz5pTWrVvLmTNnPPYRGRkpzZo1k+zZs0uBAgWkf//+cuPGDY9tNmzYIFWrVpXg4GApVaqUzJkz57a+TwAAENj8Goh27dolp06dci1r1qwxjz/99NPmtk+fPrJs2TJZtGiRbNy40VxktVWrVq7nx8XFmTAUExMj27Ztk7lz55qwM3ToUNc2x48fN9vUq1dP9u3bJ71795bnn39eVq1a5Yd3DAAAAlEmy7IsCRAaVpYvXy5HjhwxF2TLnz+/zJs3T5566imz/vDhw1KuXDnZvn27PPjgg7JixQpp3ry5CUoFCxY020yfPl0GDhwof/75p2TLls38/+uvv5affvrJ9Tpt27aVixcvysqVK1NULi1L7ty55dKlS1zLDACAdOJWvr8Dpg+R1vJ8+umn0qVLF9NstmfPHomNjZUGDRq4tilbtqwUK1bMBCKltxUrVnSFIdWoUSNzAA4cOODaxn0f9jb2PryJjo42+3BfAABAxhUwV7tfunSpqbXp1KmTuX/69GlTw5MnTx6P7TT86Dp7G/cwZK+31yW1jYaca9euSWhoaIKyjBkzRt544w25XbQf1Llz59K8n3z58pnACAAA0mkg+uijj6RJkyZSuHBhfxdFBg0aJH379nXd1/BUtGjRfywMlSlbTq5fu5rmfYWEZpeIw4cIRQAApMdA9Ntvv8m3334rixcvdj0WHh5umtG01si9lkhHmek6e5udO3d67Msehea+TfyRaXpf2xK91Q4pHY2my+2gNUMahsKa95OsYakPXbHnT8j55RPN/ghEAACkw0A0e/ZsM2ReR4PZqlWrJlmzZpW1a9ea4fYqIiLC1KjUqlXL3Nfb0aNHy9mzZ83zlY5U07BTvnx51zbffPONx+vpNvY+AoWGoeDwUv4uBgAAjuT3TtU3b940gahjx46SJcv/z2faK7xr166m6Wr9+vWmk3Xnzp1NkNERZqphw4Ym+Dz33HPyww8/mKH0gwcPNnMX2TU83bt3l2PHjsmAAQPMKLX3339fFi5caIb0AwAABEQNkTaVaa2Pji6Lb/LkyRIUFGRqiHTkl44O00Bjy5w5sxmm36NHDxOUcuTIYYLViBEjXNuULFnSDLvXADRlyhQpUqSIzJw50+wLAAAgIAKR1vIkNhVSSEiITJ061SyJKV68eIImsfjq1q0re/fuTXNZAQBAxuT3JjMAAAB/IxABAADHIxABAADHIxABAADHIxABAADHIxABAADHIxABAADHIxABAADHIxABAADHIxABAADHIxABAADHIxABAADHIxABAADHIxABAADHIxABAADHIxABAADHIxABAADHIxABAADHIxABAADHIxABAADHIxABAADHIxABAADHIxABAADHIxABAADHIxABAADHIxABAADHIxABAADHIxABAADHIxABAADHy+LvAgC3S2RkpJw7dy7N+8mXL58UK1bMJ2UCAAQGAhEcE4bKlC0n169dTfO+QkKzS8ThQ4QiAMhACERwBK0Z0jAU1ryfZA0rmur9xJ4/IeeXTzT7IxABQMZBIIKjaBgKDi/l72IAAAIMnaoBAIDjEYgAAIDjEYgAAIDjEYgAAIDjEYgAAIDjEYgAAIDj+T0Q/fHHH9K+fXsJCwuT0NBQqVixouzevdu13rIsGTp0qBQqVMisb9CggRw5csRjH3/99Ze0a9dOcuXKJXny5JGuXbtKVFSUxzY//vijPPLIIxISEiJFixaVcePG3bb3CAAAAptfA9GFCxekdu3akjVrVlmxYoUcPHhQJk6cKHfeeadrGw0u77zzjkyfPl2+++47yZEjhzRq1EiuX7/u2kbD0IEDB2TNmjWyfPly2bRpk7zwwguu9ZcvX5aGDRtK8eLFZc+ePTJ+/HgZPny4fPjhh7f9PQMAgMDj14kZ33rrLVNbM3v2bNdjJUuW9Kgdevvtt2Xw4MHSokUL89jHH38sBQsWlKVLl0rbtm3l0KFDsnLlStm1a5dUr17dbPPuu+9K06ZNZcKECVK4cGH57LPPJCYmRmbNmiXZsmWTChUqyL59+2TSpEkewQkAADiTX2uIvvrqKxNinn76aSlQoIDcf//9MmPGDNf648ePy+nTp00zmS137txSs2ZN2b59u7mvt9pMZochpdsHBQWZGiV7mzp16pgwZNNapoiICFNLFV90dLSpVXJfAABAxuXXQHTs2DGZNm2alC5dWlatWiU9evSQl19+WebOnWvWaxhSWiPkTu/b6/RWw5S7LFmySN68eT228bYP99dwN2bMGBO87EVrsQAAQMbl10B08+ZNqVq1qrz55pumdkibr7p162b6C/nToEGD5NKlS67lxIkTfi0PAADIwIFIR46VL1/e47Fy5cpJZGSk+X94eLi5PXPmjMc2et9ep7dnz571WH/jxg0z8sx9G2/7cH8Nd8HBwWbEmvsCAAAyLr8GIh1hpv143P38889mNJjdwVoDy9q1a13rtT+P9g2qVauWua+3Fy9eNKPHbOvWrTO1T9rXyN5GR57Fxsa6ttERaWXKlPEY0QYAAJzJr4GoT58+smPHDtNkdvToUZk3b54ZCt+zZ0+zPlOmTNK7d28ZNWqU6YC9f/9+6dChgxk51rJlS1eNUuPGjU1T286dO2Xr1q3y0ksvmRFoup169tlnTYdqnZ9Ih+cvWLBApkyZIn379vXn2wcAAAHCr8PuH3jgAVmyZInpszNixAhTI6TD7HVeIduAAQPkypUrpn+R1gQ9/PDDZpi9TrBo02H1GoLq169vRpe1bt3azF1k047Rq1evNkGrWrVqki9fPjPZI0PuAQCA3wORat68uVkSo7VEGpZ0SYyOKNPapaRUqlRJNm/enKayAgCAjMnvl+4AAADwNwIRAABwPAIRAABwPAIRAABwPAIRAABwPAIRAABwPAIRAABwPAIRAABwPAIRAABwPAIRAABwPAIRAABwPAIRAABwPAIRAABwPAIRAABwPAIRAABwPAIRAABwPAIRAABwPAIRAABwPAIRAABwPAIRAABwPAIRAABwPAIRAABwPAIRAABwPAIRAABwPAIRAABwPAIRAABwPAIRAABwPAIRAABwPAIRAABwPAIRAABwPAIRAABwPAIRAABwPAIRAABwPAIRAABwPAIRAABwPAIRAABwPAIRAABwPAIRAABwPAIRAABwPAIRAABwPL8GouHDh0umTJk8lrJly7rWX79+XXr27ClhYWGSM2dOad26tZw5c8ZjH5GRkdKsWTPJnj27FChQQPr37y83btzw2GbDhg1StWpVCQ4OllKlSsmcOXNu23sEAACBz+81RBUqVJBTp065li1btrjW9enTR5YtWyaLFi2SjRs3ysmTJ6VVq1au9XFxcSYMxcTEyLZt22Tu3Lkm7AwdOtS1zfHjx8029erVk3379knv3r3l+eefl1WrVt329woAAAJTFr8XIEsWCQ8PT/D4pUuX5KOPPpJ58+bJY489Zh6bPXu2lCtXTnbs2CEPPvigrF69Wg4ePCjffvutFCxYUKpUqSIjR46UgQMHmtqnbNmyyfTp06VkyZIyceJEsw99voauyZMnS6NGjW77+wUAAIHH7zVER44ckcKFC8vdd98t7dq1M01gas+ePRIbGysNGjRwbavNacWKFZPt27eb+3pbsWJFE4ZsGnIuX74sBw4ccG3jvg97G3sf3kRHR5t9uC8AACDj8msgqlmzpmniWrlypUybNs00bz3yyCPy999/y+nTp00NT548eTyeo+FH1ym9dQ9D9np7XVLbaMi5du2a13KNGTNGcufO7VqKFi3q0/cNAAACi1+bzJo0aeL6f6VKlUxAKl68uCxcuFBCQ0P9Vq5BgwZJ3759Xfc1PBGKAADIuPzeZOZOa4PuvfdeOXr0qOlXpJ2lL1686LGNjjKz+xzpbfxRZ/b95LbJlStXoqFLR6PpevcFAABkXAEViKKiouSXX36RQoUKSbVq1SRr1qyydu1a1/qIiAjTx6hWrVrmvt7u379fzp4969pmzZo1JsCUL1/etY37Puxt7H0AAAD4NRC9+uqrZjj9r7/+aobNP/nkk5I5c2Z55plnTN+drl27mqar9evXm07WnTt3NkFGR5iphg0bmuDz3HPPyQ8//GCG0g8ePNjMXaS1PKp79+5y7NgxGTBggBw+fFjef/990ySnQ/oBAAD83ofo999/N+Hn/Pnzkj9/fnn44YfNkHr9v9Kh8UFBQWZCRh35paPDNNDYNDwtX75cevToYYJSjhw5pGPHjjJixAjXNjrk/uuvvzYBaMqUKVKkSBGZOXMmQ+4BAEBgBKL58+cnuT4kJESmTp1qlsRoJ+xvvvkmyf3UrVtX9u7dm+pyAgCAjC2g+hABAAD4A4EIAAA4HoEIAAA4HoEIAAA4HoEIAAA4HoEIAAA4HoEIAAA4HoEIAAA4HoEIAAA4HoEIAAA4HoEIAAA4HoEIAAA4HoEIAAA4HoEIAAA4HoEIAAA4HoEIAAA4HoEIAAA4HoEIAAA4HoEIAAA4HoEIAAA4XhZ/FwBIjw4dOpTmfeTLl0+KFSvmk/IAANKGQATcgrioCyKZMkn79u3TvK+Q0OwScfgQoQgAAgCBCLgFN6OjRCxLwpr3k6xhRVO9n9jzJ+T88oly7tw5AhEABAACEZAKGoaCw0v5uxgAAB+hUzUAAHA8AhEAAHA8AhEAAHA8AhEAAHC8VHeqvnLlimzcuFEiIyMlJibGY93LL7/si7IBAAAEbiDau3evNG3aVK5evWqCUd68ec3w4ezZs0uBAgUIRAAAIOM3mfXp00eeeOIJuXDhgoSGhsqOHTvkt99+k2rVqsmECRN8X0oAAIBAC0T79u2Tfv36SVBQkGTOnFmio6OlaNGiMm7cOHnttdd8X0oAAIBAC0RZs2Y1YUhpE5n2I1K5c+eWEydO+LaEAAAAgdiH6P7775ddu3ZJ6dKl5dFHH5WhQ4eaPkSffPKJ3Hfffb4vJQAAQKDVEL355ptSqFAh8//Ro0fLnXfeKT169JA///xTPvzwQ1+XEQAAIPBqiKpXr+76vzaZrVy50pdlAgAAuK2YmBEAADheimuIqlatKmvXrjXNY9qHKFOmTIlu+/333/uqfAAAAIETiFq0aCHBwcHm/y1btvwnywQAZvSqDtZIq3z58kmxYsV8UiYAGVeKA9GwYcO8/t9Xxo4dK4MGDZJXXnlF3n77bfPY9evXzXxH8+fPN3MdNWrUSN5//30pWLCgxy9N7dC9fv16yZkzp3Ts2FHGjBkjWbL8/7e2YcMG6du3rxw4cMDMlzR48GDp1KmTz98DAN/Qn+syZcvJ9WtX07yvkNDsEnH4EKEIgO87VeuQ+5s3b0rNmjU9Hv/uu+/MRI3una5Tur8PPvhAKlWqlGBG7K+//loWLVpk5jh66aWXpFWrVrJ161azPi4uTpo1aybh4eGybds2OXXqlHTo0MHMk6Qj4dTx48fNNt27d5fPPvvMNPs9//zzZpScBiwAgUdrhjQMhTXvJ1nDiqZ6P7HnT8j55RPN/ghEAHweiHr27CkDBgxIEIj++OMPeeutt0wwSqmoqChp166dzJgxQ0aNGuV6/NKlS/LRRx/JvHnz5LHHHjOPzZ49W8qVK2cuFfLggw/K6tWr5eDBg/Ltt9+aWqMqVarIyJEjZeDAgTJ8+HDJli2bTJ8+XUqWLCkTJ040+9Dnb9myRSZPnkwgAgKchqHg8FL+LgYAB0jVKDMNIdrJOj7tbK3rbjVcaQ1OgwYNPB7fs2ePxMbGejxetmxZ81fe9u3bzX29rVixokcTmoacy5cvm+Yxe5v4+9Zt7H14o81zug/3BQAAZFypCkTaufrMmTMJHtcmK/e+O8nRvkE6Ik37/MR3+vRpU8OTJ08ej8c1/Og6exv3MGSvt9cltY2GnGvXrnktl5ZHm+jsRfsdAQCAjCtVgahhw4amA7Q2a9kuXrxoLuz6+OOPp2gfes0z7UCt/XpCQkIkkNjvzV64PhsAABlbqvoQTZgwQerUqSPFixc3zWRq3759puZFr2eWEtokdvbsWY+mN+0kvWnTJnnvvfdk1apVEhMTY4KWey2R1kxpJ2qltzt37vTYr11z5b5N/NosvZ8rVy4JDQ1NtAbMnmIAAABkfKmqIbrrrrvkxx9/lHHjxkn58uWlWrVqMmXKFNm/f3+Km5fq169vttcgZS86Ok07WNv/19FiOirMFhERYYbj1qpVy9zXW92HBivbmjVrTNjRctnbuO/D3sbeBwAAQKpqiFSOHDnkhRdeSPUL33HHHXLfffcl2GdYWJjr8a5du5r5g/LmzWtCTq9evUyQ0RFmdtOdBp/nnnvOhDPtL6RzDGlHbbuGR4fba42Tjorr0qWLrFu3ThYuXGiG8wMAAKQpEB05csRMhqi1MzonkbuhQ4f65Ojq0PigoCBp3bq1x8SMNp3zaPny5WZiRg1KGqh0YsYRI0a4ttEh9xp+dE4jrcUqUqSIzJw5kyH3AAAgbYFI5wzSEKJT4msfHffrmun/UxuIdEZpd9rZeurUqWZJjPZj+uabb5Lcb926dWXv3r2pKhMAAMj4UhWIdALF0aNHmwkQAQAAHNmp+sKFC/L000/7vjQAAADpJRBpGNLLZgAAADi2yaxUqVIyZMgQc00xvXSGDo939/LLL/uqfAAAAIEZiD788EPJmTOnbNy40SzutFM1gQgAAGT4QHT8+HHflwQAACA99SGy6aU1dPboGzdu+K5EAAAA6SEQXb161cwinT17dqlQoYK5nIbSmaTHjh3r6zICAAAEXiDSq8H/8MMPZiJF9yvVN2jQQBYsWODL8gEAAARmH6KlS5ea4KPXFHOfpVpri3755Rdflg8A0uzQoUNp3ofOzF+sWDGflAdABglEf/75pxQoUCDB41euXPEISADgT3FRF3Toq7Rv3z7N+woJzS4Rhw8RioAMKlWBqHr16uaCqdpnSNkhSC+aqhdZBYBAcDM6SsSyJKx5P8kaVjTV+4k9f0LOL58o586dIxABGVSqAtGbb74pTZo0kYMHD5oRZnoVef3/tm3bEsxLBAD+pmEoOLyUv4sBIKN1qn744Ydl3759JgzpTNV6GQ9tQtu+fbtUq1bN96UEAAAItBoidc8998iMGTN8WxoAAID0EojseYcSQxs7AADI8IGoRIkSSY4mi4uLS0uZAAAAAj8Q7d271+N+bGyseWzSpEkyevRoX5UNAAAgcANR5cqVvQ7FL1y4sIwfP15atWrli7IBAAAE/sVd4ytTpozs2rXLl7sEAAAIzBqiy5cve9y3LEtOnTolw4cPl9KlS/uqbAAAAIEbiPLkyZOgU7WGoqJFi8r8+fN9VTYAAIDADUTr1q3zCERBQUGSP39+KVWqlGTJkuqpjQAAAPwiVemlbt26vi8JAABAeupUPWbMGJk1a1aCx/Wxt956yxflAgAACOxA9MEHH0jZsmUTPF6hQgWZPn26L8oFAAAQ2IHo9OnTUqhQoQSPaz8iHW0GAACQ4QORjibbunVrgsf1MZ2cEQAAIMN3qu7WrZv07t3bXLLjscceM4+tXbtWBgwYIP369fN1GQEAAAIvEPXv31/Onz8vL774osTExJjHQkJCZODAgTJo0CBflxEAACDwApHOQaSjyYYMGSKHDh2S0NBQM0N1cHCw70sIAAAQyNcy087Vf/31l9xzzz0mDOls1QAAAI4IRNpcVr9+fbn33nuladOmrpFlXbt2pQ8RAABwRpNZnz59JGvWrBIZGSnlypVzPd6mTRvp27evTJw40ZdlxC3QJsy0ypcvnxQrVswn5QEAIMMGotWrV8uqVaukSJEiHo9rP6LffvvNV2XDLYiLuqCdu6R9+/Zp3ldIaHaJOHyIUAQAcIxUBaIrV65I9uzZEzyu/YnoWO0fN6OjRCxLwpr3k6xhRVO9n9jzJ+T88oly7tw5AhEAwDFSFYgeeeQR+fjjj2XkyJGuUWc3b96UcePGSb169XxdRtwCDUPB4aX8XQwAADJ+INLgo52qd+/ebeYh0gkZDxw4YGqIvM1gDQAAkOFGmd13333y888/y8MPPywtWrQwTWitWrWSvXv3miH4AAAAGbqGSC/X0bhxY3NV+9dff/2fKRUAAEAg1xDpcPsff/zRJy8+bdo0qVSpkuTKlcsstWrVkhUrVrjWX79+XXr27ClhYWGSM2dOad26tZw5c8ZjHzr0v1mzZqaTd4ECBcxlRW7cuOGxzYYNG6Rq1aqmw3epUqVkzpw5Pik/AABwcJOZDu3+6KOP0vziOmx/7NixsmfPHtMfSS8Uq01w2h/Jnu9o2bJlsmjRItm4caOcPHnSNM3Z4uLiTBjSfkzbtm2TuXPnmrAzdOhQ1zbHjx8322hn73379pmL0j7//PNm2gAAAIBUd6rWGphZs2bJt99+K9WqVZMcOXJ4rJ80aVKK9vPEE0943B89erSpNdqxY4cJSxq65s2bZ4KSmj17tpkIUtc/+OCDZj6kgwcPmnIULFhQqlSpYka+6UVmhw8fLtmyZTNNeyVLlnRNFqnP37Jli0yePFkaNWrEWQAAAG6thujYsWNmeP1PP/1kmqDuuOMO07laO1Pbi9bCpIbW9syfP9900NamM6010v5KDRo0cG1TtmxZMzfO9u3bzX29rVixoglDNg05ly9fdtUy6Tbu+7C3sffhTXR0tNmH+wIAADKuW6oh0pmo9bpl69evd12q45133vEIJLdq//79JgBpfyHtJ7RkyRIpX768CVZaw5MnTx6P7fW19KKySm/jv7Z9P7ltNORcu3ZNQkNDE5RpzJgx8sYbb6T6PQEAgAxcQxT/avbaAVprdNKiTJkyJvx899130qNHD+nYsaNpBvOnQYMGyaVLl1zLiRMn/FoeAAAQgH2IEgtIqaG1QDryS2l/pF27dsmUKVNM7ZN2lr548aJHLZGOMgsPDzf/19udO3d67M8ehea+TfyRaXpfR7V5qx1SOhqNS5AEDh1JqJcS8fdFbwEAGdctBSK9RIcu8R/zJe2jpH14NBzpEP+1a9ea4fYqIiLCfDlqE5vSW+2IffbsWTPkXq1Zs8aEHW12s7f55ptvPF5Dt7H3gcCmn3eZsuXk+rWr/i4KACADu6VApDVCnTp1ctWeaL+f7t27Jxhltnjx4hQ3TTVp0sR0lP7777/NiDKdM0iHxOfOnVu6du0qffv2lbx585qQ06tXLxNkdISZatiwoQk+zz33nLmciPYXGjx4sJm7yC6jlu+9994zlxfp0qWLrFu3ThYuXChff/31rbx1+InWDGkYSutFa68d2y2XNn/q07IBABwaiLR/T/z5iNJCa3Y6dOhgOmprANJJGjUMPf7442a9Do0PCgoyNURaa6Sjw95//33X8zNnzizLly83fY80KGkw0zKOGDHCtY0Oudfwo3MaaVOcDuefOXMmQ+4ddtHa2PP0AwMA+CgQ6TxAvpTc5I4hISEydepUsySmePHiCZrE4qtbt66ZEgAAAMBnM1UDAABkJAQiAADgeAQiAADgeAQiAADgeAQiAADgeAQiAADgeAQiAADgeAQiAADgeAQiAADgeAQiAADgeAQiAADgeLd0LTPgVkRGRpqr1afFoUOHfFYeAAASQyDCPxaGypQtJ9evXfV3UQAASBaBCP8IrRnSMBTWvJ9kDSua6v1cO7ZbLm3+1KdlAwAgPgIR/lEahoLDS6X6+bHnT/i0PAAAeEMgAgBkuP6HKl++fFKsWDGflAkZH4EIAJAh+x+GhGaXiMOHCEVIEQIR/pHRXYwOA+DP/ofa3H5++USzPwIRUoJABA9xURdEMmWS9u3b+7soABwsrf0PgVtFIIKHm9FRIpbF6DAAgKMQiOAVo8MAAE5CIAIA+ASz0yM9IxABANKM2emR3hGIAABpxuz0SO8IRAAAn6H/IdKrIH8XAAAAwN8IRAAAwPEIRAAAwPEIRAAAwPEIRAAAwPEIRAAAwPEYdg/4kS9m5Y2Ojpbg4OA07ydfvnw+uSo4sxUDSI8IRIAfxEVdEMmUSdq3b5/2nWUKErFupnk3wcEh8sUX/5VChQqleh+nTp2S1k89LdHXr6W5PABwOxGIAD+4GR0lYlk+m9U3rfu5/vsBubhupjRv3lx8gdmKAaQ3BCIgA8zq65P9+DCgMVsxgPSGQATAhSADwKkYZQYAAByPQAQAAByPQAQAABzPr4FozJgx8sADD8gdd9whBQoUkJYtW0pERITHNtevX5eePXtKWFiY5MyZU1q3bi1nzpxJMO9Js2bNJHv27GY//fv3lxs3bnhss2HDBqlataqZr6VUqVIyZ86c2/IeAQBA4PNrINq4caMJOzt27JA1a9ZIbGysNGzYUK5cueLapk+fPrJs2TJZtGiR2f7kyZPSqlUr1/q4uDgThmJiYmTbtm0yd+5cE3aGDh3q2ub48eNmm3r16sm+ffukd+/e8vzzz8uqVatu+3sGAACBx6+jzFauXOlxX4OM1vDs2bNH6tSpI5cuXZKPPvpI5s2bJ4899pjZZvbs2VKuXDkToh588EFZvXq1HDx4UL799lspWLCgVKlSRUaOHCkDBw6U4cOHS7Zs2WT69OlSsmRJmThxotmHPn/Lli0yefJkadSokV/eOwAACBwB1YdIA5DKmzevudVgpLVGDRo0cG1TtmxZc3mB7du3m/t6W7FiRROGbBpyLl++LAcOHHBt474Pext7H94uhaDPd18AAEDGFTCB6ObNm6Ypq3bt2nLfffeZx06fPm1qePLkyeOxrYYfXWdv4x6G7PX2uqS20aBz7do1r32bcufO7VqKFk39RHUAACDwBUwg0r5EP/30k8yfP9/fRZFBgwaZ2ip7OXGCyeYAAMjIAmKm6pdeekmWL18umzZtkiJFirgeDw8PN52lL1686FFLpKPMdJ29zc6dOz32Z49Cc98m/sg0vZ8rVy4JDQ1NUB4dieaLq4cDAID0wa81RJZlmTC0ZMkSWbdunen47K5atWqSNWtWWbt2resxHZavw+xr1apl7uvt/v375ezZs65tdMSahp3y5cu7tnHfh72NvQ8AAOBsWfzdTKYjyL788kszF5Hd50f77WjNjd527dpV+vbtazpaa8jp1auXCTI6wkzpMH0NPs8995yMGzfO7GPw4MFm33YtT/fu3eW9996TAQMGSJcuXUz4WrhwoXz99df+fPsAACBA+LWGaNq0aaaPTt26daVQoUKuZcGCBa5tdGh88+bNzYSMOhRfm78WL17sWp85c2bT3Ka3GpTat28vHTp0kBEjRri20ZonDT9aK1S5cmUz/H7mzJkMuQcAAP6vIdIms+SEhITI1KlTzZKY4sWLyzfffJPkfjR07d27N1XlBAAAGVvAjDIDAABw9CgzAACQPkVGRsq5c+fSvJ98+fKZiZf9hUAEAABSHYbKlC0n169dlbQKCc0uEYcP+S0UEYgAAECqaM2QhqGw5v0ka1jqr+oQe/6EnF8+0eyPQAQAANJVU9ehQ4fMrYah4PBSkp4RiAAAcBhfNnVlFAQiAHA4X9YUwFlNXdeO7ZZLmz+VjIBABAAORk2Bs6W1qSv2fMa5+DmBCAAcjJoC4H8IRAAAagrgeMxUDQAAHI9ABAAAHI9ABAAAHI8+RABwG4eW++p6Tb66fhTD5YH/IRABQDLioi6IZMok7du3D4jrNTFUHvA9AhEAJONmdJSIZQXM9Zp8NVReMVwe+B8CEQCkUKBdr8kX5WG4PPA/BCIAuM3S2m+Hfj+A7xGIACAd9kUC4FsEIgBIZ32R6PcD+B6BCABuMy6TAQQeJmYEAACORyACAACORyACAACORyACAACORyACAACORyACAACORyACAACORyACAACORyACAACORyACAACOx6U7AABIRyIjI+XcuXNp2sehQ4d8Vp6MgkAEAEA6CkNlypaT69eu+rsoGQ6BCACAdEJrhjQMhTXvZy4SnFrXju2WS5s/9WnZ0jsCEQAA6YyGoeDwUql+fuz5Ez4tT0ZAp2oAAOB4BCIAAOB4BCIAAOB4BCIAAOB4dKoGAOA2YP6gwObXQLRp0yYZP3687NmzR06dOiVLliyRli1butZbliXDhg2TGTNmyMWLF6V27doybdo0KV26tGubv/76S3r16iXLli2ToKAgad26tUyZMkVy5szp2ubHH3+Unj17yq5duyR//vxm+wEDBtz29wsAcCbmDwp8fg1EV65ckcqVK0uXLl2kVatWCdaPGzdO3nnnHZk7d66ULFlShgwZIo0aNZKDBw9KSEiI2aZdu3YmTK1Zs0ZiY2Olc+fO8sILL8i8efPM+suXL0vDhg2lQYMGMn36dNm/f795vTx58pjtAAAZly9qVPLlyyfFihVL0z6YPyjw+TUQNWnSxCzeaO3Q22+/LYMHD5YWLVqYxz7++GMpWLCgLF26VNq2bWtO9JUrV5qan+rVq5tt3n33XWnatKlMmDBBChcuLJ999pnExMTIrFmzJFu2bFKhQgXZt2+fTJo0iUAEABlUXNQFkUyZpH379mneV0hodok4fCjNoUgxf1DgCtg+RMePH5fTp0+bmh1b7ty5pWbNmrJ9+3YTiPRWa3rsMKR0e206++677+TJJ58029SpU8eEIZvWMr311lty4cIFufPOOxO8dnR0tFlsWssEAEg/bkZH6V/Waa6R0QByfvlEU8Pji0CEwBWwgUjDkNIaIXd6316ntwUKFPBYnyVLFsmbN6/HNtrcFn8f9jpvgWjMmDHyxhtv+PgdAQBut7TWyMA5GHbvxaBBg+TSpUuu5cQJqigBAMjIAjYQhYeHm9szZ854PK737XV6e/bsWY/1N27cMCPP3Lfxtg/314gvODhYcuXK5bEAAICMK2ADkTZzaWBZu3atR18e7RtUq1Ytc19vdTi+Dtu3rVu3Tm7evGn6Gtnb6PB+HYFm0xFpZcqU8dpcBgAAnMevgSgqKsqM+NLF7kit/9f5GjJlyiS9e/eWUaNGyVdffWWGy3fo0MGMHLPnKipXrpw0btxYunXrJjt37pStW7fKSy+9ZDpc63bq2WefNR2qu3btKgcOHJAFCxaYeYr69u3rz7cOAAACiF87Ve/evVvq1avnum+HlI4dO8qcOXPM5Ik6V5EOj9eaoIcfftgMs7fnIFI6rF5DUP369V0TM+rcRe4j01avXm0mZqxWrZqZT2Lo0KEMuQcAAIERiOrWrWvmG0qM1hKNGDHCLInREWX2JIyJqVSpkmzevDlNZQUAOFdaJ3jkkhuBL2CH3QMAkJEmeERgIxABAPAPT/DIJTcCH4EIAIBkcMmNjC9gh90DAADcLgQiAADgeAQiAADgeAQiAADgeAQiAADgeAQiAADgeAQiAADgeAQiAADgeAQiAADgeAQiAADgeAQiAADgeAQiAADgeAQiAADgeAQiAADgeAQiAADgeAQiAADgeAQiAADgeAQiAADgeAQiAADgeAQiAADgeAQiAADgeAQiAADgeAQiAADgeAQiAADgeAQiAADgeAQiAADgeAQiAADgeAQiAADgeAQiAADgeAQiAADgeAQiAADgeAQiAADgeAQiAADgeAQiAADgeAQiAADgeAQiAADgeI4KRFOnTpUSJUpISEiI1KxZU3bu3OnvIgEAgADgmEC0YMEC6du3rwwbNky+//57qVy5sjRq1EjOnj3r76IBAAA/c0wgmjRpknTr1k06d+4s5cuXl+nTp0v27Nll1qxZ/i4aAADwsyziADExMbJnzx4ZNGiQ67GgoCBp0KCBbN++PcH20dHRZrFdunTJ3F6+fNnnZYuKivrfa54+Kjdjrqd6P7HnT7Af9sN+2E+6LxP7ceh+/vrd9Z3oy+9ae1+WZSW/seUAf/zxhx4Ja9u2bR6P9+/f36pRo0aC7YcNG2a2Z2FhYWFhYZF0v5w4cSLZrOCIGqJbpTVJ2t/IdvPmTfnrr78kLCxMMmXKlCB9Fi1aVE6cOCG5cuXyQ2nTJ45b6nDcUofjdus4ZqnDcQus46Y1Q3///bcULlw42W0dEYjy5csnmTNnljNnzng8rvfDw8MTbB8cHGwWd3ny5EnyNfQD5OS/dRy31OG4pQ7H7dZxzFKH4xY4xy137twp2s4RnaqzZcsm1apVk7Vr13rU+uj9WrVq+bVsAADA/xxRQ6S0Caxjx45SvXp1qVGjhrz99tty5coVM+oMAAA4m2MCUZs2beTPP/+UoUOHyunTp6VKlSqycuVKKViwYJr2q01rOrdR/CY2JI3jljoct9ThuN06jlnqcNzS73HLpD2r/fbqAAAAAcARfYgAAACSQiACAACORyACAACORyACAACORyACAACORyBKo6lTp0qJEiUkJCREatasKTt37vR3kQLa8OHDzeVP3JeyZcv6u1gBZ9OmTfLEE0+Y6eb1GC1dutRjvQ4O1SkkChUqJKGhoeZCxUeOHBEnS+6YderUKcG517hxY3G6MWPGyAMPPCB33HGHFChQQFq2bCkREREe21y/fl169uxpLl+UM2dOad26dYKZ/50kJcesbt26Cc637t27i5NNmzZNKlWq5JqNWidGXrFiRcCcZwSiNFiwYIGZ8FHnTvj++++lcuXK0qhRIzl79qy/ixbQKlSoIKdOnXItW7Zs8XeRAo5OGqrnkwZub8aNGyfvvPOOTJ8+Xb777jvJkSOHOff0F4pTJXfMlAYg93Pv888/F6fbuHGj+RLasWOHrFmzRmJjY6Vhw4bmeNr69Okjy5Ytk0WLFpntT548Ka1atRKnSskxU926dfM43/Tn1smKFCkiY8eOlT179sju3bvlsccekxYtWsiBAwcC4zzz5VXlnaZGjRpWz549Xffj4uKswoULW2PGjPFruQLZsGHDrMqVK/u7GOmK/pguWbLEdf/mzZtWeHi4NX78eNdjFy9etIKDg63PP//cT6UM7GOmOnbsaLVo0cJvZUovzp49a47fxo0bXedW1qxZrUWLFrm2OXTokNlm+/btfixp4B4z9eijj1qvvPKKX8uVHtx5553WzJkzA+I8o4YolWJiYkzK1aYKW1BQkLm/fft2v5Yt0GnTjjZr3H333dKuXTuJjIz0d5HSlePHj5vZ1t3PPb14oTbZcu4lbcOGDaaJo0yZMtKjRw85f/68v4sUcC5dumRu8+bNa27195zWgLifb9rMXaxYMc63RI6Z7bPPPjMXF7/vvvtk0KBBcvXqVT+VMPDExcXJ/PnzTa2aNp0FwnnmmEt3+Nq5c+fMBxr/0h96//Dhw34rV6DTL+05c+aYLyStQn7jjTfkkUcekZ9++sm0xyN5GoaUt3PPXgfvzWVa/V6yZEn55Zdf5LXXXpMmTZqYX7aZM2f2d/ECgl70unfv3lK7dm3zJa70nNILZOfJk8djW863xI+ZevbZZ6V48eLmj78ff/xRBg4caPoZLV68WJxs//79JgBp8772E1qyZImUL19e9u3b5/fzjECE20q/gGzauU4Dkv7SWLhwoXTt2tWvZUPG1rZtW9f/K1asaM6/e+65x9Qa1a9f369lCxTaL0b/OKFfX9qP2QsvvOBxvukACD3PNIzreedUZcqUMeFHa9X++9//mouua3+hQECTWSppNaj+VRm/B7zeDw8P91u50hv9a+Dee++Vo0eP+rso6YZ9fnHupY022erPMefe/7z00kuyfPlyWb9+ven8atNzSrsIXLx40WN7zrfEj5k3+sefcvr5li1bNilVqpRUq1bNjNbTgRBTpkwJiPOMQJSGD1U/0LVr13pUnep9rQ5EykRFRZm/mPSvJ6SMNvnoLwj3c+/y5ctmtBnnXsr9/vvvpg+R08897YOuX+zadLFu3TpzfrnT33NZs2b1ON+06Uf7/jn1fEvumHmjtSLK6edbfPq9GR0dHRDnGU1maaBD7rW6r3r16lKjRg15++23TQexzp07+7toAevVV181c8VoM5kOqdQpC7Sm7ZlnnvF30QIuKLr/JakdqfUXqnba1E6G2mdh1KhRUrp0afPLeMiQIaavgs6H4lRJHTNdtL+azmuiYVJD+IABA8xfqjpdgdObfObNmydffvml6cdn99fQjvo6x5XeanO2/r7T46jzx/Tq1ct8ST344IPiRMkdMz2/dH3Tpk3NnDrah0iHlNepU8c01TrVoEGDTLcJ/R32999/m2OkTdarVq0KjPPstoxly8Deffddq1ixYla2bNnMMPwdO3b4u0gBrU2bNlahQoXM8brrrrvM/aNHj/q7WAFn/fr1Zrhp/EWHjttD74cMGWIVLFjQDLevX7++FRERYTlZUsfs6tWrVsOGDa38+fObob3Fixe3unXrZp0+fdpyOm/HTJfZs2e7trl27Zr14osvmiHS2bNnt5588knr1KlTllMld8wiIyOtOnXqWHnz5jU/n6VKlbL69+9vXbp0yXKyLl26mJ89/f2vP4v6e2v16tUBc55l0n9uT/QCAAAITPQhAgAAjkcgAgAAjkcgAgAAjkcgAgAAjkcgAgAAjkcgAgAAjkcgAgAAjkcgApAonUF29uzZ/i4GAPzjCEQAvPrhhx/k+eef/8emzc+UKZMsXbpUMjInvEcgoyAQAQ7SqVMn8yWti15IsWDBgvL444/LrFmzzEUWbRcuXJB27drJ/PnzpVy5cpIeDR8+XKpUqeLXMpw6dcpcuwlA4CMQAQ7TuHFj80X966+/yooVK6RevXryyiuvSPPmzeXGjRtmmzvvvFN++uknqV27tr+LG5BiY2NTtJ1eSDY4OPgfLUtMTMw/un/AKQhEgMPoF7R+Ud91111StWpVee2118xVuzUczZkzJ9HmnoEDB8q9994r2bNnl7vvvluGDBniEQy0iU3DlV79W69UXa1aNdm9e3eSZTl37pw8+eSTZp+lS5eWr776yrUuLi7OXP26ZMmS5griZcqUkSlTpng8X6+UXaNGDcmRI4fkyZPHBLjffvvNvA+9ur2Wya4Rs9/bpEmTpGLFiuY5RYsWlRdffFGioqKSLKc+f9q0afKvf/3LPG/06NHmcT1uegxDQkLMMdHXtENl/GOoAVTvL1682Bwnfc+VK1eW7du3e7zWjBkzTLl0vR4bLa++t/g1XzNnzjTHRl9bXbx40TRx5s+f3xz/xx57zLz/lH4+X3zxhVSoUMGcHyVKlJCJEycmeUyADOe2XUYWgN/pld9btGjhdV3lypWtJk2auO7rr4clS5a47o8cOdLaunWrdfz4ceurr76yChYsaL311luu9RUqVLDat29vHTp0yPr555+thQsXWvv27Uu0LLr/IkWKWPPmzbOOHDlivfzyy1bOnDmt8+fPm/UxMTHW0KFDrV27dlnHjh2zPv30U3MF7AULFpj1sbGxVu7cua1XX33VOnr0qHXw4EFrzpw51m+//Waubt+vXz9TJr1ati76mJo8ebK1bt068z7Wrl1rlSlTxurRo0eSx03LWqBAAWvWrFnWL7/8Yl5j06ZNVq5cucxr6mN61e4SJUpYw4cP93oM9fX0ftmyZa3ly5dbERER1lNPPWWu/q3vRW3ZssUKCgqyxo8fb9ZPnTrVXDFd36dt2LBhVo4cOazGjRtb33//vfXDDz+Yxxs0aGA98cQT5njp8df3HxYW5jqeSX0+u3fvNq87YsQI87p61fbQ0FCPK94DGR2BCHCQpAJRmzZtrHLlyiUaiOLTL+1q1aq57t9xxx0mHKSU7n/w4MGu+1FRUeaxFStWJPqcnj17Wq1btzb/1y963X7Dhg1et9XgoCEvOYsWLTLBIbmy9u7d2+Ox+vXrW2+++abHY5988olVqFChJAPRzJkzXesPHDhgHtOQYn8GzZo189hnu3btEgSirFmzWmfPnnU9tnnzZhPOrl+/7vHce+65x/rggw+S/XyeffZZ6/HHH/d4rH///lb58uWTPC5ARkKTGQBDv7+1SScxCxYsME1S2tyWM2dOGTx4sERGRrrW9+3b1zTZNGjQQMaOHSu//PJLsq9ZqVIl1/+1KUqbcs6ePet6bOrUqaZpR5uB9DU//PBD12vmzZvXdBJv1KiRPPHEE6Y5TftGJefbb7+V+vXrmyZDbT567rnn5Pz583L16tUkn1e9enWP+9oENWLECFMue+nWrZspQ1L7cn/PhQoVMrf2e46IiDBNgO7i31fFixc3x8S9LNrsFxYW5lGe48ePuz6HpD6fQ4cOJegvpvePHDlimi4BJyAQAXB9KWqfFG+0n4uOOmvatKksX75c9u7dK6+//rpHh17t23LgwAFp1qyZrFu3TsqXLy9LlixJ8jV1pJs7DWT2aDcd4fbqq6+afkSrV6+Wffv2SefOnT1eU+dI0rI99NBDJrBpH6cdO3Yk+nraj0c7j2so0T4ze/bsMaErJZ2TNbC50wCifYa0XPayf/9+EyLsfj3JvWc7gLqP8EsJb2XRcOVeFl00YPXv3z/Vnw/gJFn8XQAA/qdfkPpl3qdPH6/rt23bZmolNATZtPNyfBpIdNH9PPPMMyawaMfg1Ni6dasJOtrp2eat1un+++83y6BBg6RWrVoyb948M3dStmzZEtRuaADS8KEdhoOC/vf34MKFC1NVPu1MrYGjVKlS4ivacXzXrl0ej8W/n1hZTp8+LVmyZDEdohOT2OejUyvo8Xan93XbzJkzp+EdAekHgQhwmOjoaPPlqWHhzJkzsnLlShkzZoypOenQoYPX5+gIMG2q0lqbBx54QL7++muP2oVr166ZmoinnnrK1DL9/vvv5ou8devWqS6nvubHH39sZsvWfX7yySdmn3YtljYHaROajvwqXLiwCSdaO2O/Bw0Guo3WlBQpUsQ0j2l40ZFx7777rmlm0y/96dOnp6p8Q4cONcesWLFi5n1rwNKmK52uYNSoUanaZ69evaROnTpmZJmWT4Oqjv5LqilTaTOYhsGWLVvKuHHjTJA5efKk+Zw08OjosaQ+n379+pnPdeTIkdKmTRtT6/bee+/J+++/n6r3AaRL/u7EBOD2dqrWH3tdsmTJYuXPn9+MTtLRU3FxcR7bxu9UrZ1stfOxjgTTzr86Wsvu7BsdHW21bdvWKlq0qJUtWzarcOHC1ksvvWRdu3Yt0bJ467St+7NHNmkH4U6dOpnH8uTJY0aC/ec//3F1lD59+rTVsmVL04lZX1NHa+moNPt96PO1A7Y+V1/L3u+kSZPMc3QUVaNGjayPP/7YrL9w4cItlVWtXLnSeuihh8y+tFNzjRo1rA8//DDJTtV79+51rdfX1MfWr1/vekyff9ddd5l96vsbNWqUFR4enmxn8cuXL1u9evUyx147XetnoR2yIyMjU/T5/Pe//zWdqPW5xYoVM53mASfJpP/4O5QBALzTjtqHDx+WzZs3+7soQIZGkxkABJAJEyaYy6lox2ltLps7dy5NV8BtQA0RAASQf//732YG7r///tvMfq39irp37+7vYgEZHoEIAAA4HvMQAQAAxyMQAQAAxyMQAQAAxyMQAQAAxyMQAQAAxyMQAQAAxyMQAQAAxyMQAQAAcbr/B6ZoXjzU+SD6AAAAAElFTkSuQmCC",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.hist(reingresados['DIAS_REINGRESO'], bins=25, edgecolor='black')\n",
    "plt.xlabel(\"Días hasta reingreso\")\n",
    "plt.ylabel(\"Frecuencia\")\n",
    "plt.title(\"Histograma de DIAS_REINGRESO\")\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "ff06d918",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Top 10 procedimientos en reingresos (30d):\n",
      "9929    255606\n",
      "9059    194674\n",
      "9921    126490\n",
      "9923     85096\n",
      "9925     77888\n",
      "9919     71752\n",
      "8952     60565\n",
      "9918     60548\n",
      "9039     58392\n",
      "99       55342\n",
      "Name: count, dtype: int64\n"
     ]
    }
   ],
   "source": [
    "proc_cols = [f\"PROCEDIMIENTO{i}\" for i in range(1,31)]\n",
    "# Convertir a numérico y apilar\n",
    "all_proc = (\n",
    "    pd.to_numeric(reing[proc_cols].stack(), errors='coerce')\n",
    "      .dropna()\n",
    "      .astype(int)\n",
    ")\n",
    "print(\"\\nTop 10 procedimientos en reingresos (30d):\")\n",
    "print(all_proc.value_counts().head(10))\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "8c117feb",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Severidad y peso promedio según reingreso en 30 días:\n",
      "           IR_29301_SEVERIDAD  IR_29301_PESO\n",
      "READM_30D                                   \n",
      "0                    1.045950       0.829748\n",
      "1                    1.278159       1.216893\n"
     ]
    }
   ],
   "source": [
    "# Comparar severidad y peso medio según READM_30D\n",
    "grouped = df_filtered.groupby('READM_30D')[['IR_29301_SEVERIDAD','IR_29301_PESO']].mean()\n",
    "print(\"\\nSeveridad y peso promedio según reingreso en 30 días:\")\n",
    "print(grouped)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "dc4d34f6",
   "metadata": {},
   "source": [
    "Trabajamos en análisis Descriptivos adicionales para profundizar en las características del reingreso\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "id": "ec860031",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Edad – reingreso vs. no reingreso:\n",
      "              count  mean   std  min   25%   50%   75%    max\n",
      "READM_30D                                                    \n",
      "0          293138.0  48.4  26.0  0.0  29.0  55.0  70.0  103.0\n",
      "1          420507.0  38.5  27.0  0.0  13.0  36.0  63.0  105.0\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Estadísticas de edad\n",
    "print(\"Edad – reingreso vs. no reingreso:\")\n",
    "print(df_GRD.groupby('READM_30D')['EDAD'].describe().round(1))\n",
    "\n",
    "# Boxplot de edad\n",
    "plt.figure()\n",
    "sns.boxplot(x='READM_30D', y='EDAD', data=df_GRD)\n",
    "plt.xlabel(\"Reingreso 30d (0=no,1=sí)\")\n",
    "plt.ylabel(\"Edad\")\n",
    "plt.title(\"Edad vs Reingreso en 30 días\")\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "id": "0627c51a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "% Reingreso en 30d por sexo:\n",
      "READM_30D     0     1\n",
      "SEXO                 \n",
      "HOMBRE     40.4  59.6\n",
      "MUJER      41.6  58.4\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "ct = pd.crosstab(df_GRD['SEXO'], df_GRD['READM_30D'], normalize='index')*100\n",
    "print(\"\\n% Reingreso en 30d por sexo:\")\n",
    "print(ct.round(1))\n",
    "sns.barplot(x=ct.index, y=ct[1])\n",
    "plt.ylabel(\"% con reingreso 30d\")\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d1cf399c",
   "metadata": {},
   "source": [
    "| Sección     | Tasa READM\\_30D | Interpretación                                                                                                                                                                       |\n",
    "| ----------- | --------------: | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |\n",
    "| **H25–H28** |         54.17 % | Trastornos del cristalino (p. ej. cataratas). Más de la mitad reingresa en 30 días—sugiere complicaciones post-quirúrgicas o seguimientos agudos tras cirugía oftálmica.             |\n",
    "| **C81–C96** |         84.02 % | Neoplasias malignas linfáticas/hematopoyéticas. Tasa muy alta de reingreso refleja la necesidad de múltiples ciclos de tratamiento (quimioterapia, complicaciones inmunosupresoras). |\n",
    "| **T80–T88** |         50.48 % | Complicaciones de atención quirúrgica/médica. Un 1 de cada 2 pacientes reingresa: confirma que es un grupo de alto riesgo donde hay que profundizar en tipos de complicación.        |\n",
    "| **O20–O29** |         56.07 % | Trastornos maternos del embarazo. Más de la mitad reingresa en 30 días, probablemente por emergencias obstétricas o control de complicaciones (preeclampsia, hemorragias).           |\n"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": ".venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.9"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
